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Abstract
Significance: Radiation therapy (from external beams to unsealed and sealed radionuclide sources) takes
advantage of the detrimental effects of the clustered production of radicals and reactive oxygen species (ROS).
Research has mainly focused on the interaction of radiation with water, which is the major constituent of living
beings, and with nuclear DNA, which contains the genetic information. This led to the so-called target theory
according to which cells have to be hit by ionizing particles to elicit an important biological response, including
cell death. In cancer therapy, the Poisson law and linear quadratic mathematical models have been used to
describe the probability of hits per cell as a function of the radiation dose.
Recent Advances: However, in the last 20 years, many studies have shown that radiation generates ‘‘danger’’
signals that propagate from irradiated to nonirradiated cells, leading to bystander and other off-target effects.
Critical Issues: Like for targeted effects, redox mechanisms play a key role also in off-target effects through
transmission of ROS and reactive nitrogen species (RNS), and also of cytokines, ATP, and extracellular DNA.
Particularly, nuclear factor kappa B is essential for triggering self-sustained production of ROS and RNS, thus
making the bystander response similar to inflammation. In some therapeutic cases, this phenomenon is asso-
ciated with recruitment of immune cells that are involved in distant irradiation effects (called ‘‘away-from-
target’’ i.e., abscopal effects).
Future Directions: Determining the contribution of targeted and off-target effects in the clinic is still chal-
lenging. This has important consequences not only in radiotherapy but also possibly in diagnostic procedures
and in radiation protection. Antioxid. Redox Signal. 00, 000–000.
Keywords: bystander effects, nontargeted effects, abscopal effects, radiotherapy, radionuclide therapy, targeted
effects
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I. Introduction
For about one century, the paradigm of radiation bi-ology has been that cells need to be traversed by radi-
ation to be killed. Therefore, in the context of the ‘‘targeted
effects’’ of radiation, most research has focused on DNA
because it was considered to be the main if not the only
target. Radiation-induced DNA single- and double-strand
breaks (SSBs and DSBs) and base damage have been
identified and quantified. However, other nuclear compo-
nents, such as lipids and proteins, can also be affected by
radiation-targeted effects.
In the 1990s, a shift in the radiation biology paradigm
occurred on the basis of the observation that biological ef-
fects could be observed also after irradiation of non-nuclear
cell compartments (248, 276, 335). Particularly, the existence
of dynamic signaling pathways between the various subcel-
lular compartments (nucleus, endoplasmic reticulum [ER],
mitochondria, and cell membrane) needs to be taken into
account when assessing radiation-induced effects. The rather
naive idea that only the nucleus is sensitive to radiation and
that the rest of the cell is inert was progressively replaced by a
new view that considers intra- and intercellular signaling
mechanisms, leading to the expansion of the cell response to
radiation in time (long-lasting radiation-induced effects) and
also in space (off-target effects, also called nontargeted ef-
fects, such as bystander and abscopal effects).
In this review, we first summarize the main targeted and
off-target effects and the underlying molecular mechanisms.
Then, we discuss the currently available models to predict the
therapeutic efficacy and side effects of radiation exposure by
taking into account both targeted and off-target effects.
II. Targeted Effects: Oxidative Damage to DNA,
Lipids, and Proteins
The effect of ionizing radiation on cellular constituents
has been extensively studied, particularly the formation
of DNA lesions because the biological consequences of
radiation were mostly attributed to the formation of DNA
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lesions. In contrast to other biomolecules that are continu-
ously synthetized and decomposed within cells, the cell
genome is replicated only once per cell cycle. Therefore, the
integrity of the DNA structure is of major importance to
maintain the genetic information. For this reason, cells have
developed several repair systems to remove DNA lesions
and restore DNA integrity. Conversely, altered RNA, pro-
tein, and lipid molecules are discarded and replaced by
newly synthesized molecules.
A. DNA damage, targeted effects
Following irradiation, DNA damage can be produced via
two different mechanisms: (i) direct effect that induces a
direct ionization of DNA molecules, and (ii) indirect effect
mediated by water radiolysis (214) (Fig. 1). Through this
second mechanism, several reactive oxygen species (ROS)
can be generated by water radiolysis that can then react with
endogenous cellular constituents, including DNA. Most of
the DNA damage is attributed to the highly reactive hydroxyl
radical HO.
During the last four decades, a considerable amount of
work has been done to understand the chemical nature, the
mechanism, and the yield of radiation-induced DNA lesions
in irradiated cells. Concerning the chemical nature of the
DNA modifications, most of the work was performed with
isolated nucleosides used as DNA model systems (41). To-
day, about 80 different DNA modifications (including iso-
mers) have been identified (45). The chemical nature of these
modifications is not described in this review article, but in-
formation can be found in previous publications (41, 44,
254). Only few examples to highlight the complexity of the
undergoing reactions are presented, focusing on lesions that
have been observed at the cellular level.
1. Direct effect. Through the direct effect, DNA mole-
cules are directly ionized (loss of an electron), thus generating
a DNA radical cation. For each nucleoside, the decomposition
of the corresponding radical cation has been described in de-
tail, but the chemistry is different in double-stranded DNA
(dsDNA) (46). Indeed, among the DNA constituents, guanine
has the lowest oxidation potential. Therefore, even if oxidation
occurs on another base or sugar moiety, a fast electron transfer
reaction occurs from guanine to the generated radical cation,
thus repairing the initially produced radical and generating a
guanine radical cation (G+).
Consequently, in dsDNA and in cells, the direct effect of
radiation produces mostly unstable guanine radical cations
that, after decomposition, give rise typically to two guanine
chemical modifications (Fig. 2): 8-oxo-7¢8-dihydro-2¢-
deoxyguanosine (8-oxodGuo) following oxidation and the
corresponding formamidopyrimidine derivative FapydGuo
on reduction. Interestingly, it has been shown that in irradi-
ated cells, FapydGuo production is two times higher than that
of 8-oxodGuo, suggesting that cellular DNA is in a reducing
environment.
2. Indirect effect. The radiation-induced DNA lesions
produced through the indirect effect are mediated by the
initial formation of ROS due to water radiolysis. Exposure of
FIG. 1. Kinetic description of the ROS produced by water radiolysis. Ionizing radiation induces excitation and
ionization of water molecules in a very short time. Excited H2O* molecules can then dissociate to generate H
 and highly
reactive HO that can be produced also by transfer of one proton from ionized water molecules H2O
+. Ejected electrons can
be thermalized to produce hydrated electrons e-aq, or react with H
+ or O2 to produce H
 and O2
- respectively. Radical
recombination reactions also can occur, mostly after irradiation with high LET particles, leading to the production, for
example, of H2O2 or H2 through recombination of two HO
 or H radicals, respectively. H2O2, hydrogen peroxide; LET,
linear energy transfer; O2
-, superoxide anion; ROS, reactive oxygen species. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.com/ars
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water to ionizing radiation rapidly leads to the generation of
HO, ionized water (H2O
+), hydrogen radicals, and hydrated
electrons. Then, the reaction of the initially produced radicals
generates hydrogen peroxide (H2O2) and superoxide anion
(O2
-). As these ROS are also produced endogenously and
their concentration is regulated by several antioxidant de-
fense mechanisms, the radiation-induced increase of ROS
cellular level could damage cellular constituents and also
induce oxidative stress (113).
Among the ROS produced upon exposure to radiation,
HO plays a predominant role because it can react, at a
diffusion-controlled rate, with almost all biological constit-
uents. Its reactivity within DNA is well documented (43), and
about 30% of HO reacts with the sugar moiety or phosphate
group of DNA. Such reaction (69) produces SSBs. HO re-
action with the four different DNA bases has been studied in
detail. This reaction produces a plethora of DNA lesions, but
is limited by HO diffusion. Interestingly, the DNA lesions
generated by such mechanism are not different from those
produced via the direct effect, because similar radical inter-
mediates are generated by the two mechanisms. For instance,
concerning 8-oxodGuo, addition of HO to the position C8 of
guanine produces radical 1 (Fig. 2), also generated following
hydration of guanine radical cations arising from direct oxi-
dation of DNA. Similar observations have been made for all
DNA bases. One-electron oxidation of DNA bases gives rise
to similar chemical modifications as those produced by the
indirect effect of irradiation, the only difference concerns
their relative yields (42).
The relative importance of the direct and indirect effects in
the formation of radiation-induced DNA lesions is still a
matter of debate. The general idea is that for low LET (linear
energy transfer) radiation such as X- or c-rays, the direct
effect accounts for about 30% of DNA lesions (and thus 70%
is attributed to the indirect effect), and that this proportion
increases for higher LET radiations such as protons, carbons,
and a-particles. A low mean LET of 0.2 keV/lm is observed
with c/X-rays and beta radiation, while LET increases up to
4–26 keV/lm with Auger electrons and up to 50–230 keV/lm
with alpha particles. However, according to the chemical
mechanism of formation of radiation-induced DNA lesions,
the direct effect should mostly produce lesions on the gua-
nine moiety (8-oxodGuo, e.g.) as explained above, due to fast
electron transfer in DNA. Conversely, the indirect effect
should generate lesions in all DNA bases and also strand
breaks. Thus, an attempt has been made to determine the
relative formation of 8-oxodGuo compared with other oxi-
dative bases in cells after exposure to radiations with dif-
ferent LETs (78). To mimic the direct effect, a laser
irradiation at 266 nm was used because it can produce direct
DNA ionization following two-photon absorption. As ex-
pected, in these conditions, 8-oxodGuo was predominantly
formed. This indicates that an efficient electron transfer re-
action from guanine to other base radical cations (that are
produced by two-photon ionization) takes place also within
irradiated cells (vide supra). Conversely, the predominance
of 8-oxodGuo formation relative to other oxidative DNA
lesions in cellular DNA was not observed after gamma or
high-LET radiation. Indeed, it has been shown that increasing
the particle’s LET does not increase the relative formation of
8-oxodGuo compared with other DNA lesions.
This suggests that the direct effect is not increased upon
exposure to high LET radiation. Moreover, the strong cor-
relation between HO radiolytic yield and the number of
produced DNA lesions strongly suggests that DNA lesions
are predominantly produced via the indirect effect (242).
Additional work is needed to clarify this point. Particularly,
recent studies have highlighted the fact that the guanine
radical cation decomposition is affected by its environment.
Therefore, the measurement of a specific product generated
via the direct effect of radiation would be much more in-
formative than measuring 8-oxodGuo formation, because
the latter can be produced through the two mechanisms.
Indeed, it has been shown that some amino acids chemically
repair G+ (192, 193), and that addition of other amino acids
as well as polyamines to the C8 position produces other
DNA lesions (235, 285, 338), including DNA-protein
crosslink. Thus, monitoring lesions specifically produced
by the direct effect of radiation could provide additional
information to better estimate the direct effect relative
contribution.
Finally, it is interesting to note that the chemical nature
of radiation-induced DNA lesions is not different from that
of DNA lesions produced in cells subject to endogenous
FIG. 2. Mechanisms of 8-oxodGuo and FapydGuo formation through direct or indirect effects of irradiation. The
direct effect produces a guanine radical cation that, following dehydration, produces a neutral radical 1 that can also be
formed by addition of HO (produced through the indirect effect) onto the guanine moiety. Oxidation of 1 gives rise to
8-oxodGuo, whereas reduction of 1 leads to FapydGuo production. 8-oxodGuo, 8-oxo-7¢8-dihydro-2¢-deoxyguanosine;
dGuo, 2¢-deoxyguanosine. To see this illustration in color, the reader is referred to the web version of this article at www
.liebertpub.com/ars
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oxidative stress (45). This is not surprising because ROS
produced by radiation through water radiolysis are similar
to those produced endogenously, for example, HO through
the Fenton reaction (204). However, the major difference
concerns the lesion three-dimensional (3D) localization (212,
215, 330). Endogenous oxidative stress produces oxidative
lesions that should be randomly distributed on the DNA
macromolecules. These lesions, including modified DNA
bases and SSBs, can be rapidly and efficiently repaired by the
cell machinery, simply by removing the modification and
using the complementary strand to resynthesize the original
DNA sequence. After exposure to ionizing radiations, ROS
are locally produced along the particle track and this could
generate several DNA modifications at the same site (called
‘‘multiple damage sites,’’ MDS, or clustered DNA lesions)
(Fig. 3). These lesions are defined as two or more modifica-
tions per helix turn (172, 219). DNA DSBs are one of the best
examples of MDS. DSBs are produced in cells even after
exposure to very low doses of radiations, and their formation
yield increases almost linearly with the dose (102, 260, 329).
In addition, high-LET radiations, which induce more dense
ionizations, produce, relatively to SSBs, more DSBs com-
pared with low-LET radiations. In fact, when the LET of the
radiation increases, the number of DNA lesions per unit dose
(Gy) decreases (242) (due to an increased probability of
radical recombination), but at the same time, MDS com-
plexity increases (i.e., the MDS includes more DNA damage
types, such as base modifications and strand breaks). MDS
repair by the cell machinery is much more difficult as soon as
the two DNA strands are modified (262). Thus, this explains
why the harmful effect of radiation increases with higher
LET, and also why the effect of radiation is mostly attributed
to cluster DNA lesions (including DSBs and non-DSB cluster
lesions) produced by several ionizations.
However, recent works have highlighted the fact that a
single oxidation event also can produce several modifications
(called tandem lesions), composed of two adjacent modifi-
cations. For example, as illustrated in Figure 4 for a dG-dC
sequence, in the absence of oxygen, crosslinks between two
adjacent DNA bases could be produced, generating in-
trastrand crosslinks (G[8-5]C adduct) (128). Within the same
sequence, in the presence of oxygen, the reaction of the ini-
tially produced radical with O2 produces a hydroperoxide
radical that can add to the C8 position of an adjacent guanine
(or adenine) base. The resulting unstable endoperoxide un-
dergoes decomposition, producing tandem DNA lesions that
involve two adjacent DNA modifications (253), such as 8-
oxodGuo and a formylamine residue (8-oxodGuo-dF, Fig. 4)
(29). The latter observation, although obtained using isolated
DNA, indicates that a radical produced on a DNA base can
react with surrounding molecules and particularly with adja-
cent bases, giving rise to possibly two adjacent modifications.
Moreover, it has been shown that the repair of 8-oxodGuo
involved in tandem lesions is significantly reduced compared
with the repair of a single lesion (19). At the cellular level, the
decomposition reactions of an initially produced radical will
FIG. 3. Radiation-induced DNA damage. Different types of DNA lesions that could be produced by ionizing radiations,
including (A) base (B) modifications, abasic sites, SSB or DSB, intrastrand crosslink, tandem DNA lesions involving two
adjacent modifications. (B) Types of DSB and non-DSB clustered DNA lesions involving the combination of all possible
DNA lesions in one or two DNA helix turns (82). DSB, double-strand break; SSB, single-strand break. To see this
illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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strongly depend on its environment. The fact that carbon-
centered radicals can react efficiently with molecular ox-
ygen provides a partial explanation for the well-known
oxygen enhancement effect, observed in radiation biology.
As illustrated in Figure 4, the DNA lesions generated in the
absence of oxygen could be different from those created in
oxic conditions. Low oxygen concentration could indirectly
increase the lifetime of the initially produced radicals, thus
favoring the possibility of radical recombination and ulti-
mately decreasing the amount of radiation-induced DNA
lesions (250). In addition, the increased lifetime of radicals
could also promote repair, for example, by electron donation
from mild reducing amino acids (193) or antioxidant mole-
cules that could be used as radioprotectors (192).
This could provide a possible explanation for the reduced
level of lesions produced under hypoxic or anoxic conditions
(154). Nevertheless, increasing the lifetime of a radical could
also favor its reaction with other cellular constituents, leading
to the generation of more complex DNA lesions that could
compromise DNA repair (154). Indeed, the presence of
polyamines, which are highly concentrated in the nucleus of
eukaryotic cells, or of a nucleophilic amino acid could lead,
respectively, to the formation of DNA adducts (285) and
DNA-protein crosslinks (206). These DNA damage types are
repaired less efficiently than single lesions (19). These ex-
amples illustrate the complexity of the chemical reactions
that can occur in cellular DNA following exposure of cells to
ionizing radiation (47) and that can vary in oxic and hypoxic
conditions.
Although the literature on damage to mitochondrial DNA
(mtDNA) is less abundant, mtDNA also is affected by irra-
diation (358), and additional work is needed to better un-
derstand the consequences of this damage (143). This is also
true for the nucleotide pool (110) and RNA that are more
sensitive to oxidative stress (126) than DNA, which is com-
pacted and protected within the nucleus.
B. Effects of irradiation on lipids
The lipid layer of cell membranes is also a radiation target
(59, 296). Damage to lipids is mediated by ROS reaction with
polyunsaturated fatty acids (PUFA) (209). The initial step
involves the abstraction of the bisallylic position of PUFA
(Fig. 5A) either by HO or mediated by a thiyl radical (RS).
The produced carbon-centered radical is converted into a
peroxyl radical after reaction with molecular oxygen at a
diffusion-controlled rate. Then, the peroxyl radical can ab-
stract a hydrogen atom from another PUFA, inducing the so-
called peroxidation reactions (271). Decomposition of the
hydroperoxide generates breakdown molecules that contain
reactive carbonyl groups, such as malondialdehyde (MDA),
acrolein, and 4-hydroxy-2-nonenal (4-HNE). These decom-
position products could be used as markers of lipid perox-
idation reactions. Moreover, if they are not trapped by the
cellular defenses (particularly glutathione [GSH]), they could
generate secondary decomposition products because they can
react with cellular biomolecules (e.g., DNA, RNA, and also
amino acids) to generate adducts.
Lipid peroxidation can cause various biological effects:
increase in membrane permeability, disruption of ion gradi-
ents and transmembrane processes, as well as alteration of the
activity of membrane-associated proteins. Besides perox-
idation reactions, irradiation could also induce cis to trans
FIG. 4. Mechanisms of formation of complex DNA lesions (including tandem 8-oxodGuo-dF lesions and G[8-5]C
intrastrand crosslinks) at dG-dC sequences mediated by a single oxidation event. After HO reaction on the cytosine
base, in the absence of oxygen, the produced radical can react with an adjacent guanine base, thus producing a G[8-6]C
intrastrand crosslink. On the contrary, in the presence of oxygen, the cytosine radical is trapped by molecular oxygen, thus
producing a peroxyl radical. This peroxyl radical can react with an adjacent purine base, thus generating an unstable
endoperoxide that, on decomposition, gives rise to tandem lesions constituted of two adjacent oxidative DNA lesions. To
see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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isomerization of PUFA (191), thus affecting the cellular
membrane fluidity (194).
It has been clearly shown that the sphingolipid metabolism
is altered following exposure to ionizing radiations. Sphin-
golipids are one of the four major lipid constituents of the
cell membrane, in addition to phospholipids, sterols, and
glycolipids. Irradiation induces rapid formation of ceramide
through the hydrolysis of sphingolipid hydrolases and the
concomitant decrease of sphingomyelin at the plasma
membrane. Ceramide could be considered a second mes-
senger that not only has an effect on the plasma membrane
but also on intracellular signaling molecules (59).
C. Protein damage
An indirect evidence that ionizing radiations do not target
only DNA but also highly abundant proteins is given by the
effects of irradiation directed to the cytoplasm (353). The ef-
fects observed for doses as low as 1 Gy are changes in protein
expression and activity that are mostly mediated by posttran-
scriptional modifications (302) and also by chemical modifi-
cations, including oxidation or carbonylation (255, 295).
Like for DNA, a considerable amount of work has been
done to determine the reactivity of amino acids with radicals
produced by irradiation (295). Due to its fast and high reac-
tivity, HO can react with all amino acids with a reaction rate
between 107 and 1010 M-1s-1. With proteins, the reaction de-
pends mostly on HO accessibility to amino acids, used for
hydroxyl radical footprinting by mass spectrometry to detect
structural changes in protein conformation (130). The main
reaction pathway involves hydrogen attraction to produce a-
carbonyl radicals. Such radicals react with molecular oxygen
at a diffusion-controlled rate to produce the corresponding
peroxyl radicals that further decompose, inducing fragmenta-
tion of the protein backbone. Hydrogen atom abstraction could
also occur on the aliphatic chain of amino acids. Similar to
what observed for lipids, following the reaction with molecular
oxygen, the generated protein hydroperoxides could also in-
duce chain reactions in proteins, leading to a greater loss of
amino acids than for the initially formed radical (65). HO
reaction with aromatic amino acids occurs by addition onto the
aromatic ring. Addition onto tyrosine (Tyr) residues produces
the phenoxyl radical that could induce the formation of tyro-
sine dimers, involved in the formation of intra- or interprotein
crosslinks. Cysteine residues have the lowest redox potential
among amino acids; therefore, oxidation of their thiol groups is
the major modification. Two-electron oxidation of these resi-
dues generates sulfenic acid as the initial cysteine oxidation
product that may be converted to disulfides by GSH. Disulfides
could be converted back to thiols by disulfide reductases. If not
trapped by endogenous thiols, sulfenic acid can be oxidized to
generate sulfinic and sulfonic acid.
FIG. 5. Radiation-induced lipid peroxidation and sphingolipids. (A) Lipid peroxidation and formation of PUFA de-
composition products. (B) Phospholipids contain two hydrophobic long-chain fatty acids linked to an alcohol (usually glycerol)
and a hydrophilic group made of a phosphate group. Similarly, sphingolipids contain a long-chain sphingoid base (such as
sphingosine) linked via an amide to long-chain fatty acids, and to one polar head group that makes them amphipathic molecules.
Head groups differentiate sphingolipids from ceramides (phosphorylcholine constituting SM and hydroxyl group, respectively).
(C) Irradiation induces rapid formation of ceramide through the hydrolysis of SM by ASMase. 4-HNE, 4-hydroxy-2-nonenal;
ASMase, acid sphingomyelinase; MDA, malondialdehyde; PUFA, polyunsaturated fatty acids; SM, sphingomyelin. To see this
illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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In addition to oxidation, proteins could also be modified by
reduction, through reductant species produced by irradiation
(i.e., eaq
- and H). These reductant species react mostly with
thiol groups, and the reaction of H with methionine generates
a sulfuranyl radical that decomposes to produce a carbon-
centered radical. The latter is the precursor of homoserine. H
could also abstract a hydrogen atom and reduce cysteine to
produce a thiyl radical. Methionine reaction with eaq
- induces
a deamination reaction that causes a peptide break. In addition,
eaq
- reaction with cysteine generates hydrosulfide ions and an
alkyl radical, whereas reaction with disulfides produces a thiyl
radical and a thiolate ion. Reactive aldehydes, derived from
lipid peroxidation, also can react with proteins, mostly with the
nucleophilic moieties of amino acids in proteins (209) or DNA
bases (25) to generate adducts and crosslinks.
D. Targeted effects: conclusions
It is now very well documented that irradiation damages
cellular biomolecules, such as DNA, RNA, proteins, and
lipids. Most of the decomposition reactions of biomolecules
mediated by ROS produced during irradiation have been
identified. However, the complexity of the cellular media and
the possible reaction of transiently produced radicals with the
surrounding molecules lead to a great variety of cellular
processes induced by radiation that makes almost impossible
their precise description/identification. This is a matter of
concern for DNA lesions and it cannot be totally excluded
that not yet identified lesions are produced in cells exposed
to ionizing radiation. The most harmful lesions are not ne-
cessarily those produced in higher yields, such as base lesions
or SSBs that can be repaired rapidly and with high fidelity.
Radiation-induced lesions are not different from those pro-
duced by endogenous oxidative stress. However, due to their
special distribution in clusters, which hampers their repair,
they can be very harmful for the cells.
III. Nuclear-Centered View of the Cellular
Response to Radiation
While SSBs and base damages are efficiently repaired by
SSB repair (SSBR), base excision repair (BER), and nucle-
otide excision repair (NER), DNA DSBs and clustered DNA
lesions in general are mainly responsible for the final cellular
outcome on irradiation (269).
A. DNA DSB repair
DNA DSBs are detected by surveillance proteins of the
phosphatidylinositol-3-kinase (PI3K)-like kinase family,
particularly the serine/threonine protein kinase ataxia-
telangiectasia mutated (ATM), which is the main sensor
of DNA damage, and ATM- and Rad3-related (ATR)
protein (Fig. 6) (185, 231, 282). Both are actively re-
cruited to DNA DSB sites to monitor the DNA damage
response (DDR).
DDR is activated to avoid the transmission of erroneous
genetic information to daughter cells and to protect cells
from deregulated metabolism. It includes mechanisms in-
volved in DNA damage detection, signaling, and repair,
when possible (135), or in the initiation of programmed cell
death or senescence.
ATM activation is mediated via autophosphorylation on
serine 1981 (a hallmark of activated human ATM); however,
three additional autophosphorylation sites have been identi-
fied as well as a TIP60-mediated acetylation site [for review
(282)] (Fig. 6). ATM activation leads to dissociation of ATM
homodimers into monomers that will phosphorylate and ac-
tivate downstream protein kinases. These molecules will act
as transducers and effectors and in turn phosphorylate their
own substrate(s). One of the first identified targets of ATM
phosphorylation was p53 that plays a central role in the ra-
diation response. In physiological conditions, p53 has a short
half-life and is maintained at low levels by continuous ubi-
quitination catalyzed by mouse double minute 2 homologue
(MDM2). Upon phosphorylation, p53 is stabilized and ac-
cumulates and can activate proteins such as p21 involved in
cell cycle arrest by acting on cyclin-dependent kinases
(CDK). G1-S, intra S, and G2-M arrest give time for the
cells to repair lesions before entering mitosis. Moreover,
p53 participates in the activation of the intrinsic apoptosis
pathway, for instance, by activating proapoptotic molecules
of the BCL2 family, such as p53 upregulated modulator of
apoptosis (PUMA) that is involved in the release of proa-
poptotic factors (BAX/BAK) (Fig. 6). Therefore, p53 ac-
tivity can drive the final outcome of irradiated cells toward
DNA repair or apoptosis via a mitochondria-mediated cell
death process.
However, ATM full activation requires the recruitment of
the MRE11–RAD50–NBS1 (MRN) complex at DNA DSB
sites before induction of the DDR systems (nonhomologous
end-joining [NHEJ], and homology-directed repair, HDR).
The MRN complex also is phosphorylated by ATM. This
complex forms a bridge between DNA ends. Then, its nu-
clease activity, mediated by the nuclease MRE11, resects
DNA DSB ends, a crucial step for homologous recombina-
tion repair (HRR) (282). Moreover, interaction between
NBS1 and ATM is essential for maintaining ATM at DSB
sites. Breast cancer type 1 (BRCA1) and p53-binding protein
1 (53BP1) are involved in this interaction. ATM also interacts
with a mediator of DNA damage checkpoint protein 1
(MDC1) (170, 185, 231, 282). MDC1 is a DNA damage
sensor protein located at DSB sites where it binds to phos-
phorylated histone H2AX (cH2AX) and ATM. Additional
H2AX phosphorylation by ATM allows the recruitment of
more MDC1 molecules that bind to ATM and cH2AX in a
positive feedback loop, leading to ATM and cH2AX spread
over large domains (>500 kb) around DNA breaks and am-
plification of DNA DSB signaling (136, 170, 185, 231, 282).
Other ATM substrates are proteins involved in G1-S (p21),
intra-S (Fanconi anemia group D2 protein [FANCD2],
BRCA1, and structural maintenance of chromosomes protein
1 [SMC1]), and G2-M cell cycle arrest (checkpoint kinase 2
[CHK2] or DNA repair [poly(ADP-ribose) polymerase 1
(PARP1), the nuclease Artemis, C-terminal-binding protein 1-
interacting protein (CtIP), DNA-dependent protein kinase
(DNA-PK) cs84, polynucleotide kinase 3¢-phosphatase,
DNA-PK, and AKT]. These factors allow DNA repair ac-
cording to the NHEJ pathway before replication and mitosis
(147, 163). ATM is also activated and dissociated into mono-
mers by ROS via TIP60 acetylation near the FRAP-ATM-
TRRAP C terminal (FATC) domains. Moreover, H2AX
phosphorylation, sumoylation, and ubiquitination at DSB sites
participate in the recruitment of BRCA1 and 53BP1, two
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proteins involved in HRR promotion and repression, respec-
tively (135, 141, 142, 185).
ATR recognizes DSBs, but can also be activated by many
other DNA damage types. ATR is mainly involved in DNA
DSB repair via HRR that requires duplicated DNA and oc-
curs in S-phase cells with stalled replication forks or after the
G2 phase. ATR recruitment requires single-strand DNA, as
observed following DNA DSB end resection by nucleases
that are phosphorylated by ATM (e.g., CtIP and exonucle-
ase 1 [EXO1]). Then, there is a progressive switch from the
ATM to the ATR signaling cascade. ATR phosphorylates
checkpoint kinase 1 (CHK1) that is critical for the intra-S and
G2-M checkpoint response and that phosphorylates BRCA1
to trigger HRR (185).
According to this school of thought, DNA DSBs are the
central lesions on irradiation and their formation, repair, or
FIG. 6. DNA damage-mediated activation of ATM signaling pathways. (A) The DNA damage repair mechanism
includes sensors, transducers, and effectors. Sensors, such as the MRN complex, recognize the DNA structure modifications
induced by DNA DSBs. Transducers are ATM (and ATR involved in HRR) PI3K involved in phosphorylation of many
effector proteins that control cell cycle progression (CHK1 and CHK2), DNA repair (via, for instance, NHEJ mechanisms),
and apoptosis. The intrinsic apoptotic signaling pathway relies on p53 stabilization, followed by PUMA transcription and
BAX activation. MDM2 ubiquitin ligase activity plays a central role in keeping a low p53 concentration in non-ATM-
activated cells. On ATM activation, MDM2 ubiquitin ligase activity is inhibited and p53 stabilized. PUMA frees the
proapoptotic BAX/BAK proteins (members of the BCL2-family) that can transfer to mitochondria where they promote
cytochrome C, AIF, and SMAC release and further activation of caspases. In the extrinsic apoptotic signaling pathway,
death receptor (TNF-R, TRAIL-R, and FAS) activation leads to BID cleavage by caspase 8 and further release of cyto-
chrome C. ATM-mediated phosphorylation of H2AX triggers recruitment of MDC1, which in turn recruits more MRN
complexes and activated ATM to the damaged chromatin. This promotes H2AX phosphorylation and spreads ATM and
H2AX phosphorylation over a large chromatin domain. (B) ATM structure. ATM is a 350 kDa protein (3056 amino acids)
and a member of the PIKK family. It includes HEAT repeats, FAT, PI3K, and FATC domains. The HEAT repeats allow
NBS1 binding. Posttranslational modifications include autophosphorylation (at Ser 1981, Ser 367, Ser 1893, Ser 2996) and
TIP 60 acetylation at Lys 3016 (170, 185, 231, 282). AIF, apoptosis-inducing factor; ATM, ataxia-telangiectasia mutated;
ATR, ATM- and Rad3-related; BID, BH3 interacting-domain death agonist; CHK1, checkpoint kinase 1; CHK2, checkpoint
kinase 2; FAT, FRAP-ATM-TRRAP; FATC, FAT C-terminal; HEAT, Huntington-elongation factor 3-protein phosphatase
2A-TOR1; HRR, homologous recombination repair; MDC1, mediator of DNA damage checkpoint protein 1; MDM2,
mouse double minute 2 homologue; MRN, MRE11–RAD50–NBS1; NHEJ, nonhomologous end joining; PI3K,
phosphatidylinositol-3-kinase; PIKK, phosphatidylinositol 3-kinase-related kinase PUMA, p53-upregulated modulator of
apoptosis; SMAC, second mitochondria-derived activator of caspases; TNF, tumor necrosis factor; TRAIL, TNF-related
apoptosis-inducing ligand. To see this illustration in color, the reader is referred to the web version of this article at
www.liebertpub.com/ars
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nonrepair influences the cellular outcome through complex
interplays between cell death and survival signals.
B. Nuclear-centered view of the cellular response
to radiation: conclusion
DDR includes a complex network of proteins activated by
DNA lesions, mainly DSBs, produced in irradiated cells.
ATM/ATR and MRN play a major role in DDR by recruiting
proteins involved in DNA lesion detection and repair, in cell
cycle progression, and in cell metabolism (e.g., CHK1, CHK2,
p53, BRCA1). However, accumulating evidence indicates that
DNA lesions and DDR activation can also be observed in
nonirradiated cells close to irradiated cells. This suggests that
DDR is transmitted or initiated in these cells (151). We see
below (in section IV.A) that the DDR response, specifically
ATM, activates the p38 and c-JUN N-terminal kinase ( JNK)
mitogen-activated protein kinase (MAPK) pathways and also
nuclear factor-kappa B (NF-jB) that participates in intercel-
lular signaling.
IV. Off-Target Effects: An Integrated Cell
Response to Radiation
According to the United Nations Scientific Committee on
the Effects of Atomic Radiation (UNSCEAR) 2006 report,
‘‘bystander effect’’ is ‘‘the ability of irradiated cells to con-
vey manifestations of damage to neighboring cells not di-
rectly irradiated,’’ and ‘‘abscopal effect’’ is ‘‘a significant
response in a tissue that is physically separate from the region
of the body exposed to radiation’’ (314). Similarly, the In-
ternational Commission on Radiological Protection describes
FIG. 7. Schematic representation of the bystander and abscopal responses. Targeted effects are observed only in
irradiated cells, while nontargeted effects are observed in nonirradiated cells. Nontargeted effects include bystander and
abscopal responses. (A) Radiation-induced targeted effects concern (i) nuclear DNA and extranuclear targets, (ii) mtDNA,
Ca2+-mediated mitochondrial production of ROS and RNS, (iii) ER, as a Ca2+ storage place, and (iv) cell membrane, as the site
of ion channels, NADPH oxidase, growth factor and death receptor localization, lipid peroxidation leading to 4-HNE or MDA
production, and production of ceramide that acts as a second messenger or is involved in ceramide-enriched large platforms
(lipid rafts). Bystander effects are observed in neighboring cells (in contact or not with the irradiated cells) that have not been
crossed by ionizing particles. Intercellular cross talk is mediated by gap junctions (GJIC) or through the release of soluble
factors, including cytokines, ROS, and RNS. Exosomes containing mRNA, MicroRNA, and DNA can also be released. (B)
Abscopal effects are observed at long distance from the irradiation site (e.g., localized breast irradiation). Consequently, the
biological effects must be investigated at the whole-body scale. Abscopal effects may involve the immune system through the
release of DAMPs that are recognized by antigen-presenting cells (e.g., dendritic cells that will present antigenic peptides to
CD4 and CD8 T lymphocytes for immune response activation). The cell response to targeted and nontargeted effects can result
in cell death, cell transformation, or cell survival and these possible outcomes have to be taken into account in the field of cancer
therapy and radiation protection. 4-HNE, 4-hydroxy-2-nonenal; DAMPs, damage-associated-molecular-patterns; ER, endo-
plasmic reticulum; GJIC, gap junction intercellular communication; mtDNA, mitochondrial DNA; NAD(P)H, nicotine ade-
nine dinucleotide phosphate; RNS, reactive nitrogen species. To see this illustration in color, the reader is referred to the web
version of this article at www.liebertpub.com/ars
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the bystander effect of radiation as the transmission of signals
from irradiated to nonirradiated cells in a cell population,
leading to biological changes in the recipient cells (133a,
307) (Fig. 7).
Off-target effects also include induced genomic instability.
This is the delayed and stochastic appearance of genomic
alterations (chromosomal aberrations, gene mutations, and
reproductive cell death) in the offspring of irradiated (and
also of bystander) cells, although these daughter cells were
not irradiated (198, 199, 200, 201).
During the last 25 years, many studies have investigated
the molecular mechanisms underlying off-target effects. They
showed that off-target effects are the results of a huge dynamic
and integrated process initiated in irradiated cells and trans-
mitted to neighboring cells and to some extent to the whole
organism through the activation of the immune system.
A. Bystander effects
Although off-target effects were first described by Parsons
in 1954 (202), Nagasawa and Little performed one of the key
early studies that highlighted the need to rethink radiobiology
by also considering bystander effects. They used very low
mean doses of alpha particles (0.31 mGy) to demonstrate that
although <1% of cell nuclei were actually hit by radiation,
30% of cells showed an increased frequency of sister chro-
matid exchanges (205). Since then, many in vitro and in vivo
studies on bystander effects (usually detrimental for the cells)
have been performed using different radiation types (low vs.
high LET) (7, 131, 272, 278), different cell types (normal and
tumor cells) (74, 173, 177) and culture systems (two-
dimensional and 3D cell cultures) (238), and different animal
models (mammals, fish) (16, 153, 183, 292, 331, 339). By-
stander effects were observed for different biological end-
points, such as cell death, apoptosis (166, 179), gene
mutations (131, 357), cell differentiation (15), radiation-
induced adaptive responses (RIARs) (11, 223), senescence
(239), cell cycle distribution, gene expression, chromosomal
aberrations, and genomic instability (173, 198–200).
These studies showed that bystander effects depend on the
radiation dose, dose rate, and LET (104). They proposed that
the contribution of bystander effects to radiation-induced
biological effects in conventional external beam radiotherapy
(EBRT) and also in therapies using heavy ions, protons, or
radionuclides (5, 23, 31, 222, 227, 228, 339) should be taken
into account for future applications.
Many cellular components and functions contribute to the
extranuclear response to radiation. They include ceramide
production and lipid raft formation (111), tyrosine kinases
such as epidermal growth factor receptor (EGFR) (270),
cytoplasmic Ca2+ homeostasis mechanisms (304), protein
kinase C (PKC), MAPKs, JNKs (297), phospholipase C
(PLC), NF-jB-mediated cyclooxygenase-2 (COX-2) and
nitric oxide (NO) synthase (NOS) activation, and cytokines.
Approaches for investigating bystander effects rely on
conventional broadbeam and microbeam irradiation to se-
lectively irradiate a single cell or its subcompartments while
sparing neighboring cells, or on the transfer of conditioned
culture medium from irradiated to nonirradiated cells. The
main evidence for extranuclear radiation-induced effects
came from cytoplasmic irradiation using microbeams (53,
276, 335). Moreover, Gaillard et al. showed that depending
on the redox status of the irradiated cells, cytoplasm irradi-
ation by particles could also result in nuclear damage at the
origin of bystander signals (90).
ROS and reactive nitrogen species (RNS) initiate events in
targeted cells and also participate in their propagation through
self-sustained production, leading to similarities between
bystander effects and inflammation/immune response. In-
deed, the so-called damage-associated-molecular-patterns
(DAMPs) released by irradiated tissue can be detected by the
innate immune system, as observed for pathogen-associated
molecular patterns. Released factors are then recognized by
Toll-like receptors (TLRs), C-type lectin receptors, nucleo-
tide binding oligomerization domain-like receptors, and cy-
tosolic retinoic acid-inducible gene-like receptors (151) that
are expressed at the surface of immune cells.
1. Intercellular communications between irradiated and
nonirradiated cells. Bystander effects involve signaling
from irradiated cells to nonirradiated cells. The nature of the
communications between irradiated and nonirradiated cells
depends on whether cells are in contact or not. This cross talk
can be mediated by paracrine secretion in the extracellular
space of soluble factors via hemichannels formed by the
transmembrane protein connexins (Cxs) and pannexins
(Panxs) (182, 327). Cxs and Panxs are members of the tet-
raspan family in which proteins are classified according to
their molecular weight (25–62 kDa for Cxs and 1–3 kDa for
Panxs). These proteins allow the passage of ions (Ca2+, Na+)
and of low-molecular-weight molecules (nicotinamide ade-
nine dinucleotide, ATP, glutamate, GSH, prostaglandin E2
[PGE2] and inositol trisphosphate [IP3]) between the intra-
and extracellular environment, thus controlling autocrine and
paracrine signaling (68, 327). The role in bystander effects of
Cx43, the most abundant Cx in mammals, was identified very
early and has been largely investigated (9).
Cxs and Panxs can also form full channels that are called
gap junctions and mediate gap junction intercellular com-
munication (GJIC). These intercellular channels show much
higher selectivity and allow direct diffusion of factors be-
tween the cytoplasm of adjacent cells. The factors involved in
bystander effects and transiting through intercellular gap
junctions are small molecules (<1.5 kDa) and include ROS
(9, 10), RNS (187), ions (Ca2+, K+, Na+), (178, 279), lipid
peroxides (83), ATP (221), cyclic adenosine monophosphate
(cAMP), glucose, glutamate, and GSH. As hemichannels are
less selective than full gap junctions, it has been suggested
that in normal conditions only GJIC plays a role. Conversely,
in conditions of oxidative stress (e.g., on irradiation), both
channel types might be involved (224, 279).
2. Reactive oxygen and nitrogen species initiate and
propagate bystander effects. Early experiments high-
lighted the multiple roles of ROS and RNS in bystander ef-
fects. Specifically, they showed that radical scavengers
(ascorbic acid, N-acetyl l-cysteine), NOS inhibitors (NG-
nitro-l-arginine methyl ester [L-NAME]), NO scavenger (2-4-
carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
[c-PTIO] (281), antioxidant enzymes (superoxide dismutase
[SOD], catalase) (10, 303), and DNA-binding antioxidants
(methylproamine) (39) inhibit the appearance of bystander ef-
fects. For example, genomic instability due to bystander effects
can be rescued by restoring mitochondrial function through
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overexpression of manganese-dependent superoxide dis-
mutase (MnSOD) (103).
Oxidative processes that involve ROS and RNS continu-
ously occur in cells because at low concentrations (0.01–
0.001 nM for O2
- and 1–100 nM for H2O2), these molecules
contribute to essential cellular functions (Fig. 8). At higher
concentrations, they could be involved in the defense mech-
anisms against pathogens and they cause endogenous oxida-
tive damage (22). It is thought that between ten and fifty DNA
DSBs are produced per cell each day due to natural ionizing
radiation, ROS, DNA replication errors, and unintended
cleavage by nuclear enzymes (52, 262). In the cell, the con-
centrations of free radicals (O2
-, HO, NO) and nonradical
reactive species (H2O2, ONO2) are controlled by the balance
between their production and clearance rates that are regu-
lated by antioxidant compounds and enzymes, such as SOD,
glutathione peroxidase (GPx), and catalase, as well as non-
enzymatic compounds, such as a-tocopherol (vitamin E),
b-carotene, ascorbate (vitamin C), and the cellular thiol/
disulfide systems that include GSH/GSSH, thioredoxin
(TRX1 [-SH2/-SS-]), and cysteine/cystine. Antioxidants can
compete for oxidation with oxidizable substrates (at low
concentration) and ultimately delay or inhibit the oxidation of
these substrates (114). It must be noted that free amino acids,
peptides, and proteins, some of which are present at high
concentrations in cells (cysteine, tryptophan, histidine, tyro-
sine), also act as ROS scavengers (80). Reactions between
ROS and redox active amino acid residues (e.g., cysteine) can
modulate the activity of transcription factors (AP-1, NF-jB,
and hypoxia-inducible factor 1 [HIF-1]) and enzymes (e.g.,
protein tyrosine phosphatases, acid sphingomyelinase [AS-
Mase]) (168).
O2
- is one of the main endogenous cellular ROS com-
pounds (Fig. 8). It is produced by reduction of ground-state
molecular oxygen (3O2) by enzymatic (nicotine adenine di-
nucleotide phosphate [NAD(P)H], xanthine oxidase) or
nonenzymatic (semi-ubiquinone Q-, a compound of the mi-
tochondrial electron transport chain [ETC]) systems (80).
Peroxisomes also contain enzymes, namely d-amino-acid-
oxidase that contains flavin adenine dinucleotide (FAD) as
FIG. 8. Endogenous sources of ROS and enzymatic antioxidant defenses. (A) O2
-, hydroxyl radical (HO), and H2O2
are produced by endogenous sources that reduce O2. The main sources are mitochondria through ATP production and
oxidative (oxygenase, dehydrogenase, oxidase) enzymes, such as NAD(P)H, and xanthine oxidase, lipoxygenase, myelo-
peroxidase. Oxygenase enzymes (e.g., lipoxygenase) oxidize substrates by transferring one electron, while oxidizing a
cofactor [e.g., NAD(P)H] in the presence of oxygen. Dehydrogenases use organic substrates as an electron acceptor (e.g.,
quinones, NAD+). Oxidases just use O2 as an electron acceptor. The yield of radiation-induced DNA lesions (/Gy/cell) is
rather low compared with that produced by endogenous stress [averaged values from Goodhead (102), Pouget et al. (241,
245), Sage and Shikazono (262), and Ward (329)]. (B) Superoxide can be dismuted into H2O2 by the action of superoxide
dismutase enzymes that possess a metal transition ion (Mn3+, Cu2+, Fe3+, or Ni3+) to catalyze the reaction. In the presence of
M(n)+ metal ions, the resulting H2O2 can be broken down into HO
+OH- and M(n+1), according to the Fenton reaction. The
latter reaction can also be mediated by catalase and GPx (22, 76, 80). GPx, glutathione peroxidase. To see this illustration in
color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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cofactor and urate-oxidase oxidizing substrate by transferring
H to O2, leading to the formation of H2O2.
O2
-concentration is also regulated by three SODs, namely
the cytoplasmic Cu–Zn-dependent superoxide dismutase
(CuZnSOD or SOD1), the mitochondrial MnSOD (or SOD2),
and the extracellular SOD (ECSOD or SOD3), that catalyze
O2
-dismutation into the less reactive H2O2. This reaction
requires reduced transition metals, such as iron or copper
ions, and leads to the formation of the precursors of the highly
damaging hydroxyl radicals (HO), according to the Fenton
reaction (Fig. 8). In cells and in mitochondria, H2O2 can be
decomposed into H2O and O2 by GPx, catalase, or peroxir-
edoxins (Fig. 8).
The initial production of ROS by water radiolysis is lim-
ited in time, space, and quantity. If one considers that 2000
ionization events are produced per cell per Gy (for low LET
radiation), clinical doses of 2 Gy produce much less ROS
than the amount generated during standard cell metabolism
(329). For instance, a dose of 1 Gy would produce 1 · 103
DNA breaks per cell (about 1000 SSBs and 40 DSBs) (102,
241, 245), while endogenous metabolism would produce
more than 10 · 103 DNA breaks per day (262, 318).
Therefore, radiotherapy efficacy in tumor cells can be
partly explained by the amplification and prolongation in
time (hours and weeks) of the initial radiation-induced
ROS production. This would involve ROS- and RNS-
mediated activation of signaling pathways and signal
transmission to neighboring cells. The main sources of
endogenous ROS that participate in this amplification
process include mitochondria, NAD(P)H oxidases, and
other oxidases, such as xanthine oxidase, lipoxygenases,
and peroxisomes (80).
a. Mitochondria-dependent ROS production. Human-
hamster hybrid AL cells with normal (q+) or depleted (q0)
mtDNA were used to demonstrate the contribution of mito-
chondrial functions in the generation of bystander signals
from irradiated cells (53, 127, 355).
(1) Mitochondria and ROS endogenous production. Mi-
tochondria produce energy through the oxidative metabolism
of carbohydrates, lipids, and amino acids that generate
NADH via the ETC. They are also in charge of different
metabolic processes, such as the synthesis of heme,
FIG. 9. Mitochondrial electron transport chain and NAD(P)H oxidase as endogenous source of ROS. (A) NADH
and succinate produced during the citric acid cycle are used as electron donors for ATP synthesis by the ETC. ETC consists
of complex I (NADH coenzyme Q reductase), complex II (succinate dehydrogenase coenzyme Q), complex III (coenzyme
Q cytochrome C reductase), and complex IV (cytochrome C oxidase). The final acceptor molecule O2 is reduced to H2O.
However, a small percentage of electrons can leak at complex I and complex III and can reduce O2 into O2
-. (B) The
second major source of ROS is NOX. NOX contains membrane proteins (gp91phox or NOX-2 and p22phox that constitute the
flavocytochrome b558, and the small G Rap1A protein). During NOX activation (for instance, in neutrophils, or by Ca2+ or
radiation), cytosolic proteins (p40phox, p47phox, p67phox and G Rac2) are recruited to the membrane and NADPH binds to
NOX and transfer electrons to FAD and further across the membrane to O2 (108, 208). ETC, electron transport chain; FAD,
flavin adenine dinucleotide; NOX, NAD(P)H oxidase. To see this illustration in color, the reader is referred to the web
version of this article at www.liebertpub.com/ars
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nucleotides, lipids, and amino acids. They mediate the in-
tracellular homeostasis of inorganic ions. The ETC is com-
posed of four multisubunit enzyme complexes (Fig. 9):
complex I with NADH coenzyme Q reductase activity,
complex II with succinate dehydrogenase coenzyme Q ac-
tivity, complex III with coenzyme Q cytochrome C reductase
activity, and complex IV with cytochrome C oxidase activity.
Coenzyme Q (or ubiquinone) allows the electron transfer
from complex I to III, while cytochrome C is involved in the
transfer between complex III and IV. Electrons are finally
transferred to O2, leading to water formation. Intermediate
products, such as O2
- and H2O2, may also be liberated,
particularly at complex I (NADH dehydrogenase) (107) and
III (310), during or after premature leakage of electrons be-
tween ubiquinone and cytochrome C, and at complex II, to a
lower extent (151, 348).
(2) Mitochondria and irradiation. Mitochondria are essen-
tial in the intrinsic apoptosis pathway (but not in the death
receptor-mediated extrinsic pathway). Specifically, mito-
chondrial membrane permeabilization and cytochrome C
release are followed by caspase activation. The intrinsic ap-
optosis pathway involves PUMA, a proapoptotic protein that
allows BAX and/or BAK translocation to mitochondria to
signal apoptosis.
The total cellular mitochondrial volume is high (4–25% of
the cell volume, depending on the cell type and state), and
therefore, mitochondria represent a fairly substantial target
for cytoplasmic irradiation. Radiation produces many dif-
ferent types of mitochondrial damage, including mtDNA
damage. mtDNA is a circular double-stranded genome that
encodes proteins, transfer RNA, and ribosomal RNA. It lacks
protective histones and shows limited repair capability.
Therefore, on radiation exposure, mtDNA could be prefer-
entially damaged or lost (217), leading to loss of mitochon-
drial function (149, 316). Moreover, it has been shown that
microbeam irradiation with carbon ions leads to depolariza-
tion of mitochondria (323). Exposure to direct gamma radi-
ation causes mitochondrial mass increases (218), and alpha-
particle microbeam irradiation leads to mitochondrial frag-
mentation, involving dynamin-related protein 1 (DRP1), a
member of the dynamin family involved in mitochondrial
fusion and fission (348).
Cytoplasmic irradiation also has been associated with al-
tered protein synthesis and irregular mitochondrial oxidative
phosphorylation (66, 217, 348), leading to persistent oxida-
tive stress (162, 345). Yoshida et al. detected dysfunction of
complex I at 12 h postgamma irradiation, after early and
transient production of intracellular ROS (in the first min-
utes). This was followed by increased mitochondrial ROS
levels and mtDNA damage at 24 h (345). These observations
suggest that mitochondria participate in the amplification of
the initial oxidative stress through transmission of oxidative
events from one mitochondrion to the entire mitochondrial
population of a given cell. This process might involve tran-
sient Ca2+-dependent mitochondrial permeability to adjacent
mitochondria, resulting in enhanced ROS/RNS generation
(53, 162).
Chen et al. showed that in mtDNA-depleted and wild-type
AL cells treated with mitochondrial respiratory chain func-
tion inhibitors, cH2AX induction is attenuated in bystander
cells (53). Incubation of HepG2 (liver cancer) cells with
cyclosporin A, an inhibitor of cytochrome C release, before
irradiation demonstrated that cytochrome C release regulates
bystander effect-induced formation of micronuclei (MN) and
production of NO, but not of ROS (117). This indicates that
cytochrome C has an effect on inducible NOS (iNOS) that
catalyzes NO production.
Zhou et al. showed that on alpha-particle microbeam ir-
radiation, the frequency of DNA mutations is decreased in
bystander cells in cultures of skin fibroblasts with reduced
(q0) mitochondrial functions compared with wild-type (q+)
cells. Moreover, incubation with a pharmacologic inhibitor of
NF-jB activation (Bay 11-7082) or with the NO scavenger
c-PTIO reduced the DNA mutation frequency in both mutant
(q0) and wild-type (q+) cells, highlighting the role of NF-jB
and of activation of its downstream NF-jB/iNOS and NF-
jB/COX-2 signaling pathways (355).
Finally, mitochondria are affected also in nonirradiated
cells grown in culture medium from irradiated cells. Speci-
fically, changes of mitochondrial distribution, loss of mito-
chondrial membrane potential, and mitochondrial mass
(218), increased ROS and RNS production, and increased
apoptosis rates have been observed in such cells. These ef-
fects can be blocked by antioxidant treatments (180).
b. NAD(P)H oxidase-dependent ROS production. The
plasma membrane-bound NAD(P)H oxidase (NOX) is an-
other endogenous source of ROS. It is found in phagocytic
cells, such as macrophages and neutrophils (innate immuni-
ty), where it was first identified (14, 259). NOX-1 participates
in pathogen killing via the formation of O2
- by transferring
one electron from NADH or NADPH (Fig. 9) (80), which are
located on the cytoplasmic face of the plasma, endosomal, or
phagosomal membranes, to O2, which is found in the extra-
cellular space, or in the lumen of endosomes and phago-
somes. O2
- can next dismute spontaneously or via
peroxidase into H2O2 that can be transformed into hypo-
chlorous acid (HOCl) and contribute to the antimicrobial
activity of neutrophils (208).
NOX includes several subunits, such as membrane pro-
teins (gp91phox or NOX-2 and p22phox that constitute flavo-
cytochrome b558, and the small G Rap1A protein) and
cytosolic proteins (p40phox, p47phox, p67phox, and the G Rac2
protein). Flavocytochrome b558 contains heme subunits with
low oxydo-reduction potential (-225 and -265 mV at pH 7.0)
and is mainly involved, via its p67phox-mediated activation,
in O2 reduction by binding to NADPH and FAD (14). An
electron chain transport then occurs from NADPH to O2 via
FAD and heme (108). Six human NOX isoforms have been
identified in nonphagocytic cells. NOX-1, NOX-3, and NOX-
4 show similarities with NOX-2, while the DUOX (dual
oxidase) group includes DUOX-1, DUOX-2, and NOX-5.
DUOX-2 peroxidase activity leads to H2O2 formation and is
involved in the biosynthesis of thyroid hormones. NOX
proteins play different roles according to the cell types where
they are expressed and to the levels of ROS production (14).
In irradiated fibroblasts, NOX activation does not require
direct nuclear or cellular ‘‘hits’’ by alpha particles and leads
to O2
- and H2O2 generation, and also to persistent ROS
production in bystander cells (207). NOX is located in
ceramide-enriched lipid raft domains, the disruption of which
leads to NOX activity inhibition (347). For instance, trans-
forming growth factor (TGF) b1 secreted by irradiated cells
14 POUGET ET AL.
activates NOX-1 and the subsequent O2
- production in by-
stander cells (277). Moreover, TGFb1-mediated activation of
DUOX proteins and the release of the peroxidase domain by
metalloproteases (1) are required for the HOCl signaling
pathways. O2
- production by NOX might participate in the
activation of ASMase, leading to NOX activation in
ceramide-enriched domains (337). It was shown that irradi-
ation induces NOX/DUOX-1-dependent H2O2 production for
several days (6). This process involves p38 MAPK-mediated
activation of NOX via IL-13 expression. NOX can then
promote the amplification and long-term persistence of oxi-
dative stress signals (6).
c. ROS and RNS as second messengers. Most ROS, such
as HO, are very reactive and have a very short life, and thus
react within a few nm range from their site of production.
They cannot be transmitted to neighboring cells. However,
H2O2 and NO can diffuse through the cell membrane. H2O2
can cross membranes through aquaporin channels (21) and
can diffuse through the cytoplasm and plasma membranes of
neighboring cells along several cell diameters (13, 340). NO,
one of the main RNS, can damage DNA (211), is mutagenic,
and is involved in proapoptotic signal transduction (211). NO
also plays a role in blood compartment functions, including
smooth muscle tone and blood pressure regulation, platelet
activation, and vascular cell signaling. Thanks to its lipo-
philic properties and relative stability, NO can activate sig-
naling processes in adjacent cells (161).
NO is upregulated on oxidative stress and therefore can
compete for substrates with SOD by reacting with O2
- to
form the diffusible peroxynitrite (ONOO-) (13, 340). In
agreement, incubation with L-NAME (an NOS inhibitor), but
not with rotenone (an inhibitor of electron entry into complex
I of the mitochondrial ETC), leads to an increase of oxidative
stress. This suggests that constitutive levels of NO production
contribute to the regulation of mitochondrion-derived intra-
cellular oxidant generation (99). When NO concentration
increases to the level of SOD, ONOO- can rearrange into
biologically inert nitrite (NO2
-) or react with GSH to form the
NO donor GSNO (161). However, it can also spontaneously
and rapidly decompose to nitrogen dioxide (NO2) and HO
,
thereby oxidizing lipids, thiols, amino acid residues, DNA
bases, and low-molecular-weight antioxidants, as done by
ROS cellular constituents (13). NO can also modify proteins,
leading to S-nitrosylation (80, 164) or nitration, mainly ty-
rosine nitration, a marker of tissue inflammation. This post-
translational modification participates in the regulation of
cellular functions. For example, NO affects the DNA repair
mechanisms by downregulating the expression of BRCA1,
involved in HRR and cell cycle checkpoint control, while
promoting the error-prone NHEJ mechanisms. This regula-
tion seems to be mediated via tyrosine nitration of protein
phosphatase 2A (PP2A). PP2A then controls the formation of
the retinoblastoma-like protein 2 (RBL2)/E2F4 inhibitory
complex that recognizes and binds to the proximal BRCA1
promoter (341).
NO production from l-arginine is catalyzed by one of the
NOS isoforms, such as constitutive NOS (cNOS), including
neuronal NOS (nNOS or NOS1) and endothelial NOS (eNOS
or NOS3) and iNOS (known as NOS2) that are present in the
cytoplasm and subcellular organelles. Different from NOS
and eNOS, iNOS activation is independent of Ca2+. Irradia-
tion stimulates cNOS transient activation with a maximal
activity 5 min after exposure to clinical doses of 2 Gy (161).
Pretreatment with the NO scavenger c-PTIO of cells ex-
posed to microbeam with alpha particles abolishes MN for-
mation in bystander cells (280). Moreover, incubation of a
mouse leukemic monocyte macrophage cell line (RAW
264.7) with lipopolysaccharide (LPS) induces iNOS activity
and NO generation, thereby increasing DNA damage in by-
stander EL-4 lymphoma cells (97).
3. Cell membrane response to radiation. Compared
with DNA-centered approaches, relatively few radiobiolog-
ical studies have investigated the role of radiation targeted at
the cell membrane that, for long time, was considered to be
just an inactive phospholipid bilayer. However, in the 1990s,
several studies showed the production of ceramide, a cellular
second messenger of apoptosis involved in the sphingo-
myelin signaling pathway, during membrane irradiation
(111). Using lymphoblasts from patients with Niemann–Pick
disease (deficiency in ASMase activity), it was demonstrated
that this enzyme is required for radiation-induced production
of ceramide and apoptosis (263). Many studies now strongly
support the ceramide-mediated cell membrane role in the
biological effects of radiation, including cell death. More-
over, radiation resistance in Burkitt’s lymphoma cells has
been associated with defective ceramide signaling (189).
Finally, structure-modulating agents (e.g., cholesterol) and
antioxidants (e.g., tocopherol, eugenol) can modify the
membrane response to stress (194, 230).
a. Cell membrane and lipid rafts. Cell membrane con-
tains lipids (sphingolipids and glycerophospholipids), pro-
teins, and sterols (Fig. 5B).
Lipids, such as PUFA, are susceptible to free radical-
initiated oxidation (49), leading to lipid hydroperoxide for-
mation that can then be reduced by peroxidases. If not effi-
ciently reduced, lipid hydroperoxides can be degraded into
hydroxyalkenals (such as 4-HNE) that show great reactivity
toward DNA, proteins, and lipids (49).
Cholesterol and sphingolipids, among which sphingo-
myelin is the prevalent, mainly localize in the outer leaflet of
the cell membrane. They play a crucial role in signal trans-
duction and participate in cell growth, senescence, differen-
tiation, and apoptosis (122). Sphingolipids contain a long-
chain sphingoid base (such as sphingosine) linked via an
amide to long-chain fatty acids and to one polar head group,
making them amphipathic molecules (Fig. 5B). Head groups
are different in sphingolipids (phosphorylcholine), ceramides
(hydroxyl group), and glycerophospholipids (carbohydrates)
(256). Ceramide is composed of D-erythro-sphingosine and
of a fatty acid that contains 2–28 carbon atoms in the acyl
chain. Similarly, a hydrophobic moiety forms the backbone
of sphingomyelin and of other complex sphingolipids, such
as cerebrosides and gangliosides.
The concept of the cell membrane as a fluid mosaic (289) is
based on the finding that most physiological phospholipids
exhibit low melting temperatures and, therefore, most likely
exist in a liquid disordered phase. For instance, in Escher-
ichia coli, the fatty acid composition of phospholipids de-
pends on the temperature. Specifically, the proportion of
unsaturated acids increases as the temperature decreases
(67). At physiological temperature (37C), 22% of the
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phospholipid molecules have two unsaturated acyl chain
molecules, whereas this proportion is two times higher at
17C (67).
However, the notion of fluid mosaic has been reconsidered
because mammalian membranes contain very small domains
that are in a liquid ordered phase (35, 287). Indeed, sphin-
golipids, which have a much higher melting temperature than
other phospholipids in the cell membrane, interact with each
other via hydrophilic interactions between the sphingolipid
head groups. These complexes are stabilized by cholesterol
that fills the gaps between the large sphingolipid molecules.
The resulting domains are resistant to cold detergent ex-
traction (2) or mechanical disruption and are called lipid rafts
because they seem to float in the membrane. With a size of
about 50 nm, they correspond to lateral subcompartments in
the cell membrane and allow the cell membrane to exert its
cellular functions by segregation of molecules, reorganiza-
tion of receptor molecules and of membrane signaling and
trafficking.
Lipid rafts can be converted into larger membrane plat-
forms by ASMase activity that hydrolyzes sphingomyelin to
ceramide in rafts (Fig. 5B). Ceramide molecules then spon-
taneously associate to form ceramide-enriched micro-
domains that fuse into large ceramide-enriched membrane
platforms, thus altering the biophysical properties of these
membrane domains (167) (Fig. 10). ASMase is activated by
multiple stimuli, including CD95, CD40, DR5/TNF-related
apoptosis-inducing ligand (TRAIL), CD20, FcgRII, CD5,
LFA-1, CD28, cytokines, and chemotherapeutic drugs
(doxorubicin, cisplatin), and also by ionizing radiation.
Ceramide is considered the second messenger of many fac-
tors. For instance, ceramide acts as a messenger of inflam-
matory cytokines by binding and exerting a dual effect on the
cytosolic phospholipase A2 (cPLA2) involved in eicosanoid
formation (132). Ceramide is also involved in apoptosis. Its
binding to the endosomal acidic aspartate protease cathepsin
D results in the autocatalysis of the 52 kDa prepro-cathepsin
D into the enzymatically active 48/32 kDa cathepsin D iso-
forms that mediate oxidative stress-induced apoptosis (120).
It has been proposed that oxidation of cysteine 629 in
ASMase C-terminus by HO could be responsible for a
possible mechanism leading to increased ASMase enzymatic
FIG. 10. Lipid rafts: ceramide-enriched large platforms. (A) The cell membrane consists of a lipid bilayer that
includes proteins and cholesterol. According to the fluid-mosaic model, lipids can rotate laterally and between bilayers. The
lipid distribution in the cell membrane is associated with specific cellular functions. Specifically, the cell membrane can
include glycolipids, phospholipids (e.g., phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine), and sphin-
golipids, among which SM is predominant. Their resistance to disruption allowed the identification of membrane domains
enriched in ceramide. Ceramide is produced via ASMase-mediated hydrolysis of SM following RNS and ROS activation
and ASMase translocation to the outer layer of the cell membrane. Interaction between the resulting lipids and proteins leads
to the coalescence of microdomains (lipid rafts) into ceramide-enriched large platforms. (B) These platforms can promote
clustering of receptors and activation of signaling pathways. Besides its role in lipid rafts, ceramide is also a second
messenger (58, 167, 346). CER, ceramide; GPL, glycophospholipids; TM, transmembrane. To see this illustration in color,
the reader is referred to the web version of this article at www.liebertpub.com/ars
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activity (251). Moreover, the RNS ONOO- specifically ac-
tivates ASMase (48).
Ceramide is generated by ASMase in the outer leaflet of
the cell membrane or within intracellular vesicles. It might
also flip to the cytoplasmic leaflet and then interact with in-
tracellular molecules. Although the mechanisms of ceramide
translocation from one membrane leaflet to another are un-
known, ceramide can interact and activate serine/threonine
phosphatases, namely PP2A and PP1 (50, 58) (Fig. 10). Once
activated, these phosphatases act on different signaling pro-
teins, including MAPKs (AKT, c-JUN), PKC isoforms
(PKCa and f), kinase suppressor of Ras (KSR), pRB, and
BCL-2 (28, 349).
b. Lipid rafts in mitochondria-ER-associated domains.
Several recent studies indicate that ceramide is also present in
mitochondria (122). Mitochondrial ceramide could be gen-
erated via the de novo synthesis pathway through reverse
activity of ceramidase and activity of ASMase, residing in the
space between the inner and outer mitochondrial membrane.
Lipid raft domains might be involved in contact regions be-
tween ER and mitochondria, leading to the direct transfer
of Ca2+ released from ER to mitochondria (98). It has been
reported that mitochondria-ER-associated domains contain
ROS generating proteins and IP3 receptors (98). These re-
ceptors are upregulated by irradiation and are involved in
ATP-mediated Ca2+ release from ER (343). Ca2+, NO, ROS,
and molecules modulated by irradiation, such as AKT, pro-
mote IP3 receptor expression. For instance, it was shown that
inhibitors of PI3K, an upstream AKT activator, can block
Ca2+ release from ER (342).
c. Caveolae, a subgroup of membrane lipid rafts. Ca-
veolae are a subset of membrane lipid rafts that make small
invaginations in the plasma membrane, ER, and Golgi ap-
paratus. They contain caveolins that act as organizing cen-
ters for cellular signal transduction (233). Caveolin-1
contains a tyrosine 14 phosphorylation site and its phos-
phorylation leads to its accumulation at focal adhesion sites
(i.e., mechanical and biochemical hubs between cells
and extracellular matrix) and to the subsequent transmission
of extracellular signals via intracellular pathways (118).
Caveolin-1 phosphorylation at tyrosine 14 by the proto-
oncogene tyrosine protein kinase Src is involved in EGFR
and AKT activation. Caveolins serve as scaffolding proteins
and can dock signaling molecules, such as the Src kinase,
PI3K, eNOS, protein kinase A, PKC, and extracellular signal-
related kinase (ERK). The interaction between caveolin-1,
beta1 integrin, and focal adhesion kinase (FAK) enhances
cell adhesion and radioresistance by promoting phosphory-
lation of AKT and GSK-3beta, two factors involved in pro-
survival pathways (118).
d. Ion channels and lipid rafts. Ceramide-enriched
membrane platforms are involved in the regulation of po-
tassium (27) and calcium (56) channels. Calcium ion cyto-
plasmic level is critical for many cellular functions via
interaction with various signaling cascades, such as those that
involve the activation of the calcium-dependent PKC (112)
or Ca2+/calmodulin kinase (81).
Intracellular Ca2+ can activate NOX and iNOS, thereby
promoting ROS and RNS formation, respectively. It can
also modulate the activity of the transcription factors NF-jB
and AP1 that are involved in COX-2 and iNOS transacti-
vation and the subsequent release of ROS, RNS, and cyto-
kines. Moreover, it activates kinases, including PI3K/AKT
and MAPK.
In response to irradiation, Ca2+ levels increase (112, 319,
352). These changes can be described as oscillations or single
transient changes within minutes to days after irradiation.
The concentration of free Ca2+ in the cytoplasm is low
(*100 nM) in normal physiological conditions. It is con-
trolled by modulating its cellular entry from the extracellular
environment through, for example, ROS-mediated activation
of plasma membrane Ca2+ channels, or by release from in-
ternal storages where it is present at higher concentrations (up
to mM). ER is the main Ca2+ store (Fig. 11). As shown by
experiments using the PLC gamma inhibitor U73122, Ca2+
release is regulated by PLC-mediated generation of the sec-
ond messenger IP3 that binds to the IP3 receptors located at
the ER membrane (20, 305) (Fig. 11). This process is medi-
ated by activation of plasma membrane-associated receptor
tyrosine kinases, such as ERBB3 and HER1. HO and ex-
ogenous NO induce the release of calcium from intracellular
IP3 receptor-sensitive stores and they modulate the open/
closed status of Cx channels. Moreover, ROS can activate
PLC (40, 229). An increase in IP3 receptor level was observed
after a dose of 3 Gy in lymphoblastoid cells (343). Moreover,
IP3 receptor phosphorylation by AKT is associated with re-
duced Ca2+ flux from the ER to mitochondria and subse-
quently with reduced apoptosis (299).
e. The role of Ca2+ ions in bystander effects. Ca2+ ion role
as second messenger has been highlighted by several studies
using calcium chelators or blockage of voltage-gated L-type
Ca2+ channels. A rapid intracellular calcium increase was
observed in bystander keratinocytes on addition of medium
from X-ray irradiated keratinocytes. This phenomenon was
associated with increased ROS production, decreased mito-
chondrial membrane potential, and apoptosis (178, 279).
Moreover, membrane signaling and Ca2+ influx induced in
bystander cells by ROS-activated signaling factors released
from irradiated cells lead to ROS production in bystander
cells (176). Several factors could mediate the propagation of
the increased intracellular Ca2+ levels. Specifically, it was
shown that ATP released by irradiated astrocytes is the de-
terminant of calcium wave propagation over large distances
(100–250 lm) (30). ATP may act as an extracellular signal-
ing molecule by diffusing via channels that involve Cxs (61),
Panxs (298), or purinergic P2XR7 receptor channels (221,
306, 311, 313). Once in the extracellular space, ATP can
activate Ca2+-permeable channels or G-protein-coupled re-
ceptors (GPCRs) on neighboring cells, thus inducing PLC-
mediated IP3 synthesis (68). IP3 can also diffuse via mem-
brane gap junctions (266) (Fig. 11) and activate PLC in
neighboring cells.
Ca2+ released from ER can be transferred to mitochondria
through voltage-dependent anion channels (VDACs) and mi-
tochondrial Ca2+ uniporter (79, 257). Accumulated Ca2+ can
then activate mitochondrial metabolic functions and stimu-
late energy production via ATP synthase (252), and subse-
quently ROS and RNS production and release of the
proapoptotic factors cytochrome C and caspase 3. Moreover,
irradiation can modulate the expression of GRP75 and mi-
tofusin 1 and 2 (MFN 1/2), involved in ER-mitochondrial
TARGETED AND OFF-TARGET RADIATION EFFECTS 17
cross talk. It can also regulate Cx43 and Cx30 translocation to
the inner membrane of mitochondria where they participate,
as hemichannels, in Ca2+ homeostasis (68).
Studies in which human keratinocytes were incubated with
conditioned medium from gamma particle-irradiated cells in
the presence of EGTA, verapamil, nifedipine, or thapsigargin
(known to act on calcium homeostasis) showed the in-
volvement of calcium and the activation of multiple MAPK
pathways, such as the ERK, JNK, and p38, in the production
of radiation-induced bystander effects (178). Similar results
were obtained during in vitro radionuclide therapy using
Auger electron emitters (228). Other studies reported calcium
ion role in NO-mediated bystander effects through calcium-
dependent NO generation via cNOS (NOS1) or eNOS
(NOS3) (115, 279). Inhibition of cNOS leads to a decrease in
radiation-induced ERK1/2 kinase activity (161).
f. ROS/RNS and growth factor receptor activation. Lipid
raft-mediated membrane reorganization can lead to activa-
tion of receptor and nonreceptor tyrosine kinases, such as
ERBB1, that can homodimerize or heterodimerize with other
members of the ERBB receptor family (ERBB2, ERBB3, and
ERBB4) (91), insulin-like growth factor-1 (IGF-1) receptors,
and death receptors (Fig. 12). Binding of growth factors to
their tyrosine kinase receptors leads to activation of MAPK
and PI3K/AKT signaling pathways. These processes are
mediated by similar signaling pathways. Indeed, activation of
ERBB1, 2, and 3 leads to activation of RAS family members
(K-RAS, N-RAs, H-RAS) and further downstream signaling
pathways that involve MAP3K (MEKK2/3, RAF-1/B-RAF),
MAP2K (MEK1/2; MEK5), and MAPK (ERK1/2) and in
turn activate transcription factors, such as AP1, NF-jB, and
CREB (315). Similarly, death receptors activate two other
FIG. 11. Interplay between Ca21 and radiation-induced oxidative stress [extensively reviewed in Decrock et al.
(68)]. Irradiation increases the intracellular Ca2+ level (oscillations or single transient changes occurring within minutes to
days after irradiation). Radiation-induced ATP release by irradiated cells can activate ATP-gated P2X receptor cation
channels (P2X receptors) present on the cell membrane, thus allowing Ca2+ entry into the cell. It can also activate P2Y
receptors that have been identified as phospholipase C activators. Ca2+ can also be released from the ER through calcium-
induced calcium release mechanisms that involve IP3Rs or RyRs. IP3 is produced (with diacylglycerol) during hydrolysis of
phosphatidylinositol 4,5-bisphosphate (PIP2) by phospholipase C. Phospholipase C is activated by Ca2+, GPCRs, ROS,
RNS, receptor and nonreceptor tyrosine kinase (e.g., HER1 and 3). Ca2+ can activate ion channels and binds to calmodulin
before activation of the serine/threonine protein phosphatase calcineurin. Ca2+ can also activate protein kinase C that in turn
activates, by phosphorylation, the MAPK pathway and phospholipase A2, at the origin of COX-2 activity modulation. It can
activate transcription factors (NF-jB, AP1) that promote various downstream pathways (iNOS, COX-2). Released Ca2+ can
also be taken up by mitochondria via VDAC and MCU and modulation by the ER-mitochondria-tethering proteins GRP75
(mitochondrial heat shot protein HSP70) and MFN 1 and 2 (involved in mitochondrial fusion). The increase in mito-
chondrial Ca2+ level is accompanied by ROS, an RNS increase, mtDNA damage, altered ATP synthesis, mitochondrial
depolarization, and release of cytochrome C and caspase 3 that will amplify IP3R activity. COX-2, cyclooxygenase-2;
GPCRs, G-protein-coupled receptors; iNOS, inducible nitric oxide synthase; IP3, inositol trisphosphate; IP3Rs, IP3 recep-
tors; MAPK, mitogen-activated protein kinase; MCU, mitochondrial Ca2+ uniporter; MFN, mitofusin; NF-jB, nuclear
factor kappa B; RyRs, ryanodine receptors; VDAC, voltage-dependent anion channel. To see this illustration in color, the
reader is referred to the web version of this article at www.liebertpub.com/ars
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MAP3K/MAP2K/MAPK pathways resulting in the activa-
tion of p38 (a-c) kinases and JNKs (1/2). Finally, IGF-1
receptor and its downstream kinases PI3K, PDK1, and AKT
participate in mTOR activation and GSK-3 regulation. Ulti-
mately, all these different pathways result in the activation of
transcription factors involved in cell death or survival.
Radiation can modulate the production and expression
of cytokine and growth factor receptors (54, 270, 305).
For example, a 2 Gy dose can modulate the expression of
cell surface receptors, such as ERBB1 (HER1) (305). As
described above, NO and ROS produced by radiation can
lead to defective mitochondrial function due to leakage of
mitochondrial membranes, allowing the amplification of the
initial signal through massive release into the cytosol, via
Ca2+-dependent mechanisms, of O2
- anions and RNS.
These, in turn, may inhibit the activity of protein tyrosine
phosphatase by oxidation and/or nitrosylation of a key cys-
teine residue in the active site, leading to increased phos-
phorylation of many proteins, such as ERBB1 (308). Cells
lacking functional mitochondria (q0 cells) cannot inhibit such
phosphatase activities (162). Similar results were reported on
ROS scavenging by N-acetyl cysteine.
The PI3K pathway, which plays a role in the long-term
effects of cell survival, can also be activated on irradiation
(315).
It was shown that activation of growth receptors is mod-
ulated by radiation according to waves. For example, Dent
et al. found that EGFR is first activated early and for few
minutes (0–5 min) after irradiation. This is followed by a
second prolonged activation at 90–240 min postirradiation
(73). The MAPK pathways activate membrane-bound matrix
metalloproteinase (MMP) activities that promote cleavage of
proforms/zymogens of multiple growth factors into their
functionally activated forms that can in turn activate, later
after irradiation, cell surface receptors. For example, EGFR
activation could in turn promote cleavage and release of
presynthesized paracrine ligands, such as pro-TGFa (109,
315) that could contribute to sustained MAPK signaling via
an autocrine positive feedback loop involving EGFR, the
Ras-MAPK signaling pathway, and a ligand-releasing pro-
tease (284). Released factors could then bind to cells that
express EGFR or be transmitted in a paracrine way for long-
distance effects (abscopal effects). The observation that a
broad-spectrum MMP inhibitor (marimastat, BB2516),
FIG. 12. The MAPK and PI3K signaling pathways. The four major MAPK signaling pathways (ERK1/2, ERK5, JNK1/
2, and p38) regulate cell survival (ERK1/2 and ERK5) and apoptosis ( JNK1/2 and p38) via the expression of transcription
factors. The PI3K signaling pathway is involved in cell growth via AKT1/2 proteins. Death (Fas/CD95, TNF-R, DR3-5) and
growth (HER family and IGF-1 receptors) receptors are located in lipid rafts and can be activated during coalescence of
ceramide-enriched raft platform. They facilitate the cross talk between death or growth signaling from the membrane
environment and intracellular signaling cascades. FAK and PYK-2 serve as scaffold proteins to facilitate the functional
integration of focal adhesion proteins, such as paxillin, involved in Ca2+ homeostasis and can phosphorylate PI3K. ERK,
extracellular signal-related kinase; FAK, focal adhesion kinase; IGF-1, insulin-like growth factor 1; JNK, c-JUN N-terminal
kinase; PTEN, prime time entertainment network. To see this illustration in color, the reader is referred to the web version
of this article at www.liebertpub.com/ars
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known to affect tumor invasion, inhibits also growth of head
and neck squamous cell carcinoma (HNSCC) cells that
overexpress EGFR, highlighted the MMP role (e.g., MMP9)
in cleaving HER ligands from membrane-anchored precur-
sors into their functionally activated states (218a). Inhibition
of ERK/MAPK (by PD98059 or U0126) and PI3K (by
LY294002 or wortmannin) leads to a marked reduction of
both basal and induced MMP9 activity, indicating that the
MAPK signaling pathways are also required in an autocrine
loop for HER1 activation (218a).
g. MAPKs and the bystander response. The four major
MAPK signaling pathways in mammalian cells (ERK1/2,
ERK5, JNK1/2, and p38) can regulate either survival (ERK1/
2 and ERK5) or apoptosis ( JNK1/2 and p38). Inhibitors of the
ERK pathway (PD98059 and U0126), JNK pathway
(SP600125), and p38 pathway (SB203580, SB202190)
helped demonstrating the role of these signaling pathways in
bystander cell death induced by gamma/X-ray (55, 178), al-
pha particle (89), or carbon ion (77) exposure. Similar results
were obtained after radionuclide therapy with Auger electron
(228) or alpha particle-emitters (unpublished data). ROS and
RNS have a role in MAPK direct and indirect activation.
Incubation of confluent cultures of human diploid fibroblasts
with CuZnSOD or catalase after irradiation with 0.003–0.03
Gy of alpha particles inhibits p21 (WAF1) upregulation by
MAPK and the induction of MN formation in bystander cells
(10). Moreover, p21 knockout results in inactivation of
MAPK signal pathway kinases (55), and cNOS inhibition
leads to reduction of ERK1/2 kinase activity (cytoprotective
effect) (161), suggesting that diffusible NO could mediate
MAPK activation in bystander cells.
4. Central role of NF-jB in the nuclear and extranuclear
responses to radiation. Experiments showing that ATM
activates NF-jB, which is involved in iNOS and COX ac-
tivity, demonstrated the link between inflammation and DDR
(336). Therefore, as the bystander and inflammatory re-
sponses share homologies, studying the role of NF-jB in
bystander effects can be of major relevance.
a. Nuclear factor kappa B. NF-jB is a redox-sensitive
transcription factor made of five different subunits that are
organized in homo- or heterodimers: p50 (e.g., p50/p105
constitutes NF-jB1), p52 (e.g., p52/p100 constitutes NF-
jB2), p65RelA, RelB, and c-Rel (Fig. 13). All subunits have a
300-amino acid N terminal sequence (Rel Homology Do-
main) that mediates dimerization, nuclear translocation,
DNA binding, and I-jB binding. NF-jB is involved in innate
and adaptive immunity and chronic inflammation, thereby
linking the immune response to radiation response (121).
Moreover, it is a transactivator of genes involved in cell
proliferation and suppression of apoptosis induced by tumor
necrosis factor (TNF) a by blocking caspase-8 activation
(326) by induction of BCL2 (325, 326) and by transactivation
of TNF receptor-associated factor 1 (TRAF1), TNF receptor-
associated factor 2 (TRAF2), and the inhibitor-of-apoptosis
(IAP) proteins c-IAP1 and c-IAP2. It is also involved in au-
tophagy, angiogenesis, metastasis formation, tumor pro-
gression, and oncogenesis (121, 246), and is considered a
molecular target for cancer therapy (322). It participates in
the antioxidant defenses by promoting SOD expression
(139). Its inactive form binds to the inhibitor I-jB that masks
NF-jB nuclear localization signal and sequesters it in the
cytoplasm. Upon irradiation, it can be released and trans-
ferred to the nucleus (226).
Specifically, TNFa binding to its receptor (TNFR) leads to
a conformational change of TNFR that is accompanied by
binding of TNFR type 1-associated DEATH domain protein
(TRADD) to TNFR death domain. Two proteins, TRAF2 and
receptor-interacting protein (RIP), are then recruited and in
turn recruit the IjB kinase (IKK) complex, which is made of
IKK-a (IKK1), IKK-b (IKK2), and the regulatory subunit
IKK-c/NF-jB essential modulator (NEMO) (Fig. 13). IKK is
FIG. 13. NF-jB activation mechanisms. The antiapoptotic NF-jB consists of five heterodimers, among which the most
common form involves p65 and p50. It is kept in the cytoplasm by its interaction with IjB. On activation (e.g., by ATM,
TNFa, IL1), the IKK complex, which is made of IKK-a (IKK1), IKK-b (IKK2), and the regulatory subunit IKK-c/NEMO,
phosphorylates and targets IjB for ubiquitination and degradation by the proteasome, while NF-jB can enter the nucleus
and activate its target genes. IKK, IjB kinase; NEMO, NF-jB essential modulator. To see this illustration in color, the
reader is referred to the web version of this article at www.liebertpub.com/ars
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then activated and phosphorylates IjB before ubiquitination
and proteosomal degradation to release NF-jB (121, 124).
Among the plethora of targets with NF-jB responsive ele-
ment sequences, COX-2, iNOS, and also cytokines (TNFa,
IL1, IL6, IL33), chemokines (IL8, MCP-1), VEGF, ICAM1,
and VCAM1 have been identified as major factors that can
modify the microenvironment and trigger inflammation (95).
These molecules may also be involved in oncogenesis (246).
b. NF-kB and irradiation. NF-jB can be activated by
doses as low as 0.1 Gy of X-rays, but participates in the RIAR
(84) also at higher doses (2–50 Gy) (32). RIAR was dem-
onstrated by the observation that a priming dose (generally
>0.005 Gy) reduces the detrimental effects of the challenging
dose administered a few hours later (186, 333). This can be a
beneficial effect for low-dose radiation, but might induce
radioresistance during radiotherapy. Indeed, RIAR has been
associated with reduced chromosome aberrations, MN for-
mation, and mutation induction (223, 344, 356). RIAR shares
similarities with inflammation. It was shown that low irra-
diation doses lead to ATM phosphorylation that contributes
to NF-jB activation and to cell survival, in a process in-
volving also ERK (but not p38/JNK) (4, 151). ATM partic-
ipates in NF-jB activation by phosphorylating IjB and
NEMO (165) that mediate NF-jB inhibition. NF-jB acti-
vation by low-dose irradiation leads to the expression of
MnSOD 15 min postirradiation, and small interfering RNAs
(siRNAs) against MnSOD reduce RIAR (84).
RIAR is also observed in bystander cells. Indeed, a prim-
ing dose of 0.02 Gy of c-rays, delivered 6 h before single-cell
microbeam irradiation, inhibited 50% of the bystander effects
observed in control cells (no priming dose) (265).
Optimal NF-jB activation is observed at doses between 7
and 10 Gy and with high LET (90–230 keV/lm). In these
conditions, NF-jB activation is mediated by ATM recruited
at DNA DSB sites (336) and is an alternative pathway leading
to p53-mediated signaling. p53 participates in cellular redox
status by transactivating p53-induced genes (PIGs) that en-
code antioxidant molecules (GPx). In irradiated cells, p53
transactivates genes encoding ROS-generating enzymes,
such as quinone oxidoreductase (NQO1, PIG3) and proline
oxidase (POX, PIG6), BAX, PUMA, and p66SHC, thereby
leading to oxidative stress and apoptosis (168, 240). How-
ever, the ATM-activated p53 signaling pathway is not re-
quired for the bystander response (95), as indicated by the
finding that bystander effects can be observed in p53-null
cells exposed to gamma rays (350) or to Auger-emitting ra-
dionuclides (227).
Several studies reported that common p53-regulated ra-
diation response genes, such as cyclin-dependent kinase in-
hibitor 1 (CDKN1A known as p21Waf1), are upregulated in
alpha particle-irradiated normal human lung fibroblasts, and
also in bystander cells (8, 90). Genes regulated by NF-jB,
such as COX-2, IL8, and BCL2A1, also are similarly ex-
pressed in bystander and irradiated cells (95).
Following gamma or alpha irradiation, activation of NF-
jB signaling leads to the production of cytokines and che-
mokines, such as IL-1a and b, IL-6, TNFa, CXCL1, CXCL2,
and CXCL8 (121, 158) (Fig. 14). Activation can occur within
few hours following irradiation and might be ATM depen-
dent. A second activation wave can be observed after 24 h and
this might be related to receptor binding by secreted cyto-
kines, such as TNFa (24). Therefore, NF-jB could modulate
FIG. 14. The NF-jB and cytokine re-
ceptor pathways in the bystander re-
sponse. DNA DSBs in irradiated cells
activate ATM and NEMO that in turn as-
semble IKK before IjB ubiquitination and
proteosomal degradation. Released NF-jB
enters the nucleus and induces the tran-
scription of target genes, such as those en-
coding cytokines. Secreted cytokines can in
turn bind to receptors on bystander cells. On
binding, receptors will activate NF-jB-
responsive element-containing molecules
(e.g., cytokines, COX-2, and iNOS), thus
contributing to ROS and RNS production
and transmission of bystander signals in a
self-sustained process. The MAPK and
JAK2-STAT3 pathways are also activated
by IL8 and IL6, respectively. The TGFb
receptor also can activate NOS. b-Cat, b-
catenin; JAK2, Janus kinase 2; NOS, nitric
oxide synthase; STAT3, signal transducer
and activator of transcription 3; TGF,
transforming growth factor. To see this il-
lustration in color, the reader is referred to
the web version of this article at www.lie-
bertpub.com/ars
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the response of directly irradiated cells and also alert neigh-
boring nonirradiated cells via autocrine and paracrine path-
ways.
NF-jB regulates cytokine production in irradiated cells,
but it is controlled by cytokine signaling in bystander cells
(151). NF-jB-dependent expression of IL6 via IL6-receptor
complex activates the Janus kinase 2 ( JAK2)-signal trans-
ducer and activator of transcription 3 (STAT3) pathway and
STAT3-dependent gene expression, thus establishing a link
between ATM, NF-jB, and STAT3. STAT3 is a transcription
factor located in the cytoplasm and transferred to nucleus on
activation. It also maintains constitutive NF-jB activation by
prolonging NF-jB nuclear retention (105, 106). NF-jB also
transactivates IGF-1 receptor, thereby promoting PI3K/
AKT-GSK3b-b-catenin signaling pathways in both irradiated
and bystander cells (94, 119, 210) (Fig. 14).
NF-jB can also interfere with the main MAPK signaling.
More specifically, it suppresses the JNK cascade and ROS
activity (36, 232). It must be noted that TRADD, a TNFR1-
associated signal transducer, can also bind to TRAF2 that
activates NF-jB and Fas-associated protein with death do-
main (FADD), two proapoptotic factors, whereas NF-jB is a
potent antiapoptotic agent (129).
NF-jB also controls IGF-1 receptor that can activate the
downstream (PI3K)-AKT survival pathway in both directly
irradiated and bystander fibroblasts (94). In bystander cells,
GSK3b phosphorylation by AKT is accompanied by stabi-
lization of beta catenin that acts as a nuclear activator of
transcription after GSK3b phosphorylation by WNT signal-
ing (86).
5. The COX-2 and iNOS. The NOS and COX systems
include constitutive forms (NOS1, NOS3, and COX-1),
which are expressed in many cell types and are mostly in-
volved in housekeeping tasks, and inducible forms (iNOS
known as NOS2 and COX-2), which are activated in stress
conditions (294). For example, activated macrophages pro-
duce clastogenic factors, via superoxide and NO, and can
induce gene mutations, DNA base modifications, DNA
strand breaks, and cytogenetic damage in neighboring cells.
NOS1 and NOS3 are Ca2+/calmodulin dependent, while
NOS2 is much less. Inducible forms lead to NO production
from l-arginine and can be activated by irradiation (181). For
example, iNOS activation has been observed as early as 3 h
after X-ray irradiation and lasts over 24 h (187). Similarly,
NOS1 can be activated by therapeutic doses (2 Gy) and
blocks the cytoprotective effects of radiation-induced ERK1/
2 activity (161).
COX-2, also known as prostaglandin endoperoxide syn-
thase 2 (PTGS2), converts arachidonic acid into prostaglan-
din endoperoxide H2 (PGH2), a precursor of PGE2 involved
in inflammation. During this reaction, singlet oxygen can also
be released. COX-2 is an inducible enzyme responsible for
the generation of ROS and of proinflammatory PGE2 (355).
Expression of iNOS (12) and COX-2 (133) is also con-
trolled by NF-jB and is involved in secondary proin-
flammatory waves following irradiation. Conversely, cNOS
can stimulate the early signaling effects of low-dose irradi-
ation (161).
COX-2 is also upregulated in bystander normal human
fibroblasts and its inhibition by NS-398 in bystander cells
reduces mutagenesis and genetic instability (354). COX-2 is
a downstream target of MAPK pathways, such as ERK, JNK,
and p38 kinase. Zhou et al. showed that inhibition of ERK
phosphorylation suppresses COX-2-mediated bystander re-
sponse (354). Therefore, as a downstream target of the NF-
jB and MAPK/AP1 pathways, COX-2 can be induced by a
variety of molecules (TNFa, TGFb, IL6, IL8, IL33, TRAIL,
and IGF-1) (293). Finally, radiation-induced activation of
NF-jB and of its downstream regulated genes that encode
cytokines, such as IL-8, IL-6, COX-2-generated PGE2, and
IL-33, can lead to COX-2 activation in bystander cells, via
autocrine/paracrine stimulation of the NF-jB and MAPK
pathways (134).
Zhou et al. also showed that radiation-induced bystander
effects require mitochondria-dependent NF-jB/iNOS/NO
and NF-jB/COX-2/PGE2 signaling pathways (355). While
COX-2 leads to ROS production, it is interesting to note that
MnSOD is also activated by NF-jB (139), thus providing an
antioxidant role for NF-jB in agreement with its anti-
apoptotic and proliferation properties.
We mentioned above that posttranslational modifications
of p53, through phosphorylation by ATM and also by other
kinases, such as CHK2 and homeodomain-interacting protein
kinase 2 (HIPK2), contribute to its stabilization and subse-
quent induction of transcription of downstream genes in-
volved in cell cycle arrest, programmed cell death, or cell
metabolism. Accumulation of p53 also attenuates iNOS in-
duction because p53 interacts with TATA binding protein
and/or NF-jB that are essential for iNOS expression (85).
B. Distant/systemic effects
1. Immune response as the mediator of radiation-induced
systemic effects. As discussed above, ionizing radiation
can cause a variety of effects in cells directly exposed to
radiation and also in neighboring and distant nonirradiated
cells (i.e., off-target effects or systemic effects). Recent re-
views on the topic describe extensively the biological and
chemical molecules that induce and/or participate in the
propagation of these various off-target effects. The growing
number of data supports the necessity of using different ap-
proaches (i.e., bioinformatics and meta-analyses) to have a
correct picture of the governing mechanisms and type of
biological molecules that contribute to the different off-target
effects. The most recent bioinformatic studies and meta-
analyses have confirmed the interactions between mediators
of systemic effects and DNA damage response/repair (DDR/R)
components, as well as interactions between pivotal compo-
nents of the innate immune response, such as pattern recogni-
tion receptors (PRRs), and DNA repair proteins (BRCA1,
XRCC1, DNA-PK, Ku70/80, and others) (213).
Nikitaki et al. generated a detailed list of proteins involved
in different categories of radiation-induced systemic effects,
including the clinically relevant abscopal phenomenon, by
using improved methodologies of literature text-mining and
various bioinformatic tools. Many of these proteins belong to
the DDR complex network and have been found as central
hubs in the various protein/protein interaction (PPi) net-
works, indicating that the key pathways involved in off-target
effects are apoptosis, TLR-like, and NOD-like receptor sig-
naling pathways (213) (Fig. 15). PRRs are expressed by the
cells of the innate immune system to recognize two classes of
molecules and various ‘‘danger’’ signals: pathogen-associated
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molecular patterns (PAMPs), which are associated with mi-
crobial pathogens, and DAMPs, which are associated with
cellular components that are produced after cell damage or
death. In general, PRRs can recognize abnormal molecular
complexes as a consequence of infection, inflammation, or
other types of cellular stress (195). DAMPs seem to play an
important role in the communication of this stress system-wide
and in different organisms, from plants, fish, rats to humans, as
reviewed in Ref. (188). Several studies have shown that radi-
ation exposure results in the initiation of various triggering
FIG. 15. Complex DNA damage leads to immune signaling. (A) Repair of a clustered damaged DNA site: a challenging
task. On induction by ionizing radiation of complex DNA damage, such as a DSB and two oxidative DNA lesions (a
damaged base, red star, and an apurinic/apyrimidinic, AP, site), at least two DNA repair pathways and several DNA repair
proteins will be activated. For the base damage, BER is the main repair pathway, while for the DSB, only NHEJ will be
considered here for simplicity. In all cases, the most basic proteins and enzymes are described. For short-patch BER, a DNA
glycosylase will recognize and remove the damaged base and the repair should be completed by the concerted activity of AP
endonuclease 1 (APE1), a DNA polymerase, and ligase III to seal the broken ends. In the nearby DSB area (a few bp apart),
the Ku heterodimer (Ku70/80) initiates NHEJ by binding to the free DNA ends and engaging other NHEJ factors, such as
DNA-PK, XRCC4, and DNA ligase IV, to the DSB site. DNA-PK becomes activated on DNA binding and then phos-
phorylates a number of substrates, including p53, Ku, and the DNA ligase IV cofactor XRCC4. Phosphorylation of these
factors is believed to further facilitate DSB processing. For ligation, the ends must be partially processed by the nucleases
Artemis, MRE11/RAD50/NBS1 complex, and FEN-1. Moreover, as shown by advanced fluorescence microscopy, the
formation of each DSB is rapidly accompanied by phosphorylation of thousands of histone H2AX molecules (cH2AX). The
MRN complex functions as a sensor of DNA ends and activates the ATM kinase that phosphorylates CHK2, p53, and
H2AX in flanking chromosomal regions. (B). Systemic effects. Processing of clustered DNA damage can lead to unrepaired
and persistent DNA damage that can cause cell senescence or cell death (i.e., apoptosis). This can trigger the extracellular
release of different ‘‘danger’’ signals or damage-associated molecular patterns (DAMPs: ATP, short DNAs/RNAs, ROS,
heat shock proteins [HSPs], high-mobility group box [HMGB]-1, S100 proteins, and others). DAMPs activate different
PRRs, such as TLRs and the formation of inflammasomes, a process that leads usually to inflammation and immune-related
pathologies. Interestingly, recent evidence (see section IV.B.1) suggests a direct interaction between different PRRs and
DNA repair proteins. Cell damage or death can also lead to the release of several cytokines and chemokines that can
regulate immune responses. PRR activation usually results in NF-jB-mediated release of various proinflammatory cyto-
kines, such as IFNs, IL-1, IL-6, IL-8, VEGF, EGFR, and TNFa. The activation of APCs, for instance, dendritic cells and
macrophages, will induce primarily the innate immune response (activation of T cells) and most rarely the adaptive immune
response (mediated by B cells). In all cases, the constant triggering of the immune system might generate many detrimental
systemic effects for the organism. Positive immunomodulation is usually mediated by the action of regulatory (suppressor)
T cells (i.e., Treg cells), suppressor macrophages, and immunosuppressive cytokines to maintain overall tissue homeostasis.
APCs, antigen-presenting cells; BER, base excision repair; DNA-PK, DNA-dependent protein kinase; EGFR, epidermal
growth factor receptor; PRRs, pattern recognition receptors; Treg cells, regulatory T cells; TLRs, Toll-like receptors. To see
this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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mechanisms associated with the inflammation and immune
responses of the host organism, including the release of
proinflammatory cytokines and chemokines by monocytes and
macrophages. Radiation-induced cytokine gene upregulation
is frequently observed, and several genes encoding
inflammation-related cytokines (e.g., IFNs, IL-1, IL-6, IL-8,
VEGF, EGFR, and TNFa) are considered to be ‘‘early re-
sponse’’ genes that are activated within minutes to hours after
irradiation. This process is considered a genuine ‘‘danger’’
signal in response to radiation injury and it is the main source
of de novo ROS production. This secondary ROS production
can partially explain the late increase in the expression of
inflammatory cytokines in irradiated cells (268). Radiation-
generated cytokines are responsible for the formation of in-
flammatory lesions and work together with DAMPs to create
the proinflammatory, pro-oxidant microenvironment nec-
essary to characterize this site as a ‘‘stress’’ site and to induce
a systemic response. This is expected to promote maturation
of dendritic cells and, in cancer treatment, the development
of an effector T cell response (i.e., innate response to tumor-
associated antigens) (Fig. 15). This process is completed by
the attraction of cellular components of the immune system,
such as neutrophils, and then macrophages and lymphocytes
(268).
Overall, the immune response to radiation is highly related
also to the radiation sensitivity (i.e., propensity to undergo
apoptosis) of the various immune cell subsets, depending on
the lineage, maturity, and activation status. B cells and naive
T helper (Th) cells are radiation sensitive, whereas T memory
cells, natural killer T cells, and regulatory T cells (Tregs) are
more resistant (267). As presented in Figure 15, the final
balance between controlled immune response and excessive,
pathologically chronic immunogenic response is not easily
understood. Certainly, the induction of repair-resistant
complex DNA damage on exposure to ionizing radiation is
expected to trigger a persistent immune signaling through the
continuous activation of the various DNA damage check-
points that freeze cell cycle until damage is repaired, or direct
the cell toward senescence or apoptosis (92). For example, in
mice in which the ERCC1-XPF DNA repair endonuclease
has been knocked down in all cells or only in adipocytes,
DNA damage signaling activates a chronic autoinflammatory
response resulting in fat depletion. This response is cell au-
tonomous and most importantly requires ATM, a well-known
DNA damage signaling molecule (146).
The role of the innate immune system in coordinating these
response types is a rapidly emerging research area (146). As
discussed by Gasser et al. (93), the immune system uses
mislocalized or damaged DNA to discover infected or oth-
erwise diseased and malfunctioning cells. Conversely, ge-
nomic DNA and mtDNA in healthy cells are usually
overlooked by the DNA recognition pathways. Furthermore,
cells have a limited ability to degrade mislocalized DNA and
to repair any damaged DNA, possibly to prevent the un-
planned activation of DNA sensor pathways and of the in-
flammation and immune systems. It is generally accepted that
there is a multivariable alliance between DDR and immune
signaling and the modulating parameters are not always un-
derstood (234). One of the most coherent immune rebalan-
cing activities involves shifting the T cell equilibrium toward
regulatory (suppressor) T cells (i.e., Treg cells), and this can
occur after radiotherapy (267). In addition, immunomodula-
tion can be achieved also by the action of suppressor macro-
phages and immunosuppressive cytokines to secure overall
tissue homeostasis (268).
2. Abscopal effects: historical changes and clinical evi-
dence. Although modern radiotherapy is getting progres-
sively closer to its ideal target size or volume, still there are
unresolved questions; particularly, it is not clear whether ra-
diation effects are be really limited and localized. The idea of
distant, abscopal effects was introduced for the first time by
Mole in 1953 (196). Abscopal is made of the ‘‘Ab’’ prefix,
which means ‘‘away from,’’ and ‘‘scopos’’ (Latin), which
means shooting mark or target. Therefore, this adjective de-
scribes the idea of ‘‘off-target’’ or ‘‘away from target’’ effects
and supports the hypothesis of the interdependence of all body
cells (196). As suggested by Mole, this practically means that
damage to one cell will unavoidably affect the body as a
whole. This initial hypothesis was based on the finding that in
rats, the thyroid gland synthetic activity was reduced to 25% of
the normal 3 days after localized irradiation with 6–10 Gy.
However, this was not caused by whole body irradiation or
direct irradiation of the thyroid or the pituitary gland. More-
over, the thyroid function reduction was observed only when a
sufficiently large volume of the abdomen was irradiated (196).
Although the idea of abscopal effects seems logical, it has
been disregarded in radiotherapy for many years. It took
about 50 years to show clear mechanistic evidence, at least in
mice, about the immune system’s role in this phenomenon
(72). Specifically, mice bearing one syngeneic mammary
carcinoma (mouse 67NR cells derived from mammary gland
malignant neoplasms) in each flank were treated with the
growth factor Flt3-Ligand (Flt3-L; daily for 10 days) to boost
dendritic cell production, after local radiotherapy (or not) to
only one of the two tumors (single dose of 2 or 6 Gy). Growth
of the nonirradiated tumor was impaired only in mice that
received unilateral radiotherapy and Flt3-L, but not in ani-
mals treated only with Flt3-L. This result indicates that im-
munity is involved in the abscopal effect. Radiotherapy
immunostimulatory effects have created a wide interest due
to the preclinical and clinical observations that tumor-
localized radiotherapy can occasionally prompt anticancer
immune responses that facilitate the regression of distant and
nonirradiated metastatic tumors, as recently reviewed in
Wennerberg et al. (332).
Although circumstantial evidence existed since the 1950s,
abscopal effects are still considered in some cases as unex-
plained, obscure, or of limited clinical value due to the high
specificity and dependence on the type of host organism,
tumor, radiation, and so on. In the 1960s, Law and Mole (159)
showed direct (i.e., targeted) and abscopal effects of X-ray
radiation on the thymus of weanling rats. More recently,
many studies using primarily mice or rats described a variety
of ‘‘off-target’’ effects (34, 57, 137, 155, 156, 184, 216, 320,
321). Additional work is needed to precisely evaluate the type
and degree of abscopal effects in a variety of model organ-
isms [mice (264), rats, earthworms (197)] and different tar-
geted organs (head, thorax, etc.) (101, 152, 190, 236). Very
recently, Ventura et al. exploited synchrotron radiation to
study targeted radiation-induced ‘‘off-target’’ effects in
C57BL/6 mice (317). Under different radiation settings, ir-
radiation of a small leg area induced pronounced persistent
systemic genotoxic effects (such as complex DNA damage
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and cell apoptosis) also in nonirradiated areas. These geno-
toxic events were accompanied by changes in the plasma
concentrations of macrophage-derived cytokines, eotaxin,
IL10, TIMP1, VEGF, TGFb1, and TGFb2, as well as changes
in the tissue proportion of macrophages, neutrophils, and T
lymphocytes, underlying the strong links between response to
radiation and immune system.
It is now quite safe to suggest that local irradiation of a
tumor leads to cell death and tissue damage and the release of
ROS, cytokines, and danger signals, several of which can
trigger an innate immune response (144), although clinical
evidence is still rare. One of the first clinical evidences was
the description in 2009 of an abscopal effect in a patient with
chronic lymphocytic leukemia during radiation therapy
(157). One week after X-ray radiotherapy, the lymph nodes in
the neck that were not irradiated and distant from the irra-
diated area started to regress, and after 2 weeks of radio-
therapy, they showed complete regression (157). The same
year, another patient was diagnosed with acute radiation
pneumonitis and other signs of radiation toxicity after spine
irradiation. The authors suggested that this should alert cli-
nicians on the toxicity risk for nontarget organs that receive
low-dose or zero radiation (283). For a list of the reported
clinical cases concerning abscopal effects in patients with
nonhematological malignancies and treated by conventional
radiation (patient characteristics, treatment strategy, and
outcomes), the reader can refer to a relatively recent review
by Siva et al. (291).
Currently, the idea that abscopal effects exist and can be
modulated primarily via the immune system is progressively
more accepted (87, 125, 174, 261). Encouraging results based
on case reports and preclinical data suggest that radiotherapy
and immunotherapy may synergize to create a scenario of
off-target responses away from the radiation field that could
be beneficial for the patient (2, 51, 60, 70, 71, 116, 171, 273,
301). DDR mechanisms and inflammatory responses have
been recently observed in patients undergoing radiotherapy
for nonsmall-cell lung cancer. The observed abscopal effect
was also linked to changes in the plasma levels of MDC/
CCL22 and MIP-1alpha/CCL3 cytokines (290). Un-
doubtedly, one of the major breakthroughs is the finding that
the combination of radiation and immunotherapy to boost the
immune system (e.g., with the human monoclonal anti-
CTLA-4 antibody ipilimumab) induces immune-mediated
abscopal effects in poorly immunogenic preclinical tumor
models and in patients with metastatic melanoma or other
cancer types (62, 100, 237). The suggested mechanism for
this therapeutic type is that the anti-CTLA4 monoclonal an-
tibody binds to CTLA4 expressed on the surface of T cells
and inhibits the CTLA4-mediated downregulation of T cell
activation (75). This consequently leads to a boosted cyto-
toxic T lymphocyte (CTL)-mediated synergistic immune
response against cancer cells and high tumor immunity, es-
pecially when combined with radiation. Currently, the Na-
tional Cancer Institute (NCI) lists only one Phase I clinical
trial for solid cancers or lymphoma. This is a multicenter
study to evaluate the safety of an anti-CTLA-4 human
monoclonal antibody (AGEN1884) and to estimate the
maximum tolerated dose in subjects with advanced or re-
fractory cancer (Clinicaltrials.gov ID: NCT02694822).
Another early example of regression of hepatocellular
carcinoma was observed after radiotherapy (total dose of 36
Gy) for bone metastasis (220). Doses of 2 and 6 Gy have been
used in combination with the dendritic cell growth factor
Fms-related tyrosine kinase 3 (FLT3) or with injection of
dendritic cells in tumors as immune therapy (72, 150). In
mice with melanoma tumors, a single fraction of 15 Gy
showed similar results as 3 · 5 Gy and was accompanied by
the generation of tumor antigen-specific effector cells that
traffic to the tumor (175). The combination of anti-CTLA4
antibodies with fractionated irradiation (3 · 8 Gy or 5 · 6
Gy), but not single-dose irradiation (20 Gy), showed tumor
growth delay outside the field of irradiation in preclinical
models (300).
C. Off-target effects: an integrated cell response
to radiation: conclusion
It was initially thought that the harmful effects of ionizing
radiation were caused by clusters of DNA lesions, involving
DNA DSBs, in irradiated cells. However, several observa-
tions progressively modified this DNA-centered paradigm
view of radiobiology. First, the yields of radiation-induced
ROS and RNS formation and subsequently of DNA lesions
were relatively low compared with the endogenous produc-
tion [mainly by mitochondria, NAD(P)H oxidases]. Second,
DNA lesions involving DDR activation were observed in
cells that had not been traversed by radiation, but that were
close to irradiated cells (bystander effects). These bystander
effects are the consequence of oxidative stress signals initi-
ated in irradiated cells and propagated to neighboring cells. In
this context, not only the initial nuclear DNA breaks but also
all the cell compartments (cell membrane, mitochondria, ER)
and associated complex networks that involve Ca2+ release
and ROS/RNS production through NF-jB, iNOS, and COX
activation have to be considered. Increased oxidative stress in
irradiated cells and its transmission also to neighboring cells
can amplify the initial response.
Distant systemic effects of radiation, which in the clinic
are often called abscopal effects, are generally accepted
nowadays and probably complete the picture of radiation
effects in the whole body. Similarly to bystander effects, they
are initiated by local DNA damage in irradiated cells or tis-
sue. This can be considered the triggering effect that marks
the irradiated area as a ‘‘stress’’ area in the body. Distant
radiation effects involve the release of short and long distance
messengers to convey the stress signal to distant sites by the
mediation of well-conserved inflammatory and immune re-
sponse networks. In the clinic, the most extreme manifesta-
tion of this phenomenon is tumor shrinkage in distant sites
not reached by irradiation. This knowledge could pave the
way to clinical applications of this systemic effect of radia-
tion treatment.
V. Benefit/Risk Analysis
In the clinic, irradiation is used to destroy tumor cells by
triggering cell death mechanisms. Innovative technologies
and procedures have been developed in conventional EBRT,
and the use of radionuclides for both imaging and therapy has
progressively gained interest in the last two decades. Pre-
dicting the potential consequences of off-target effects is
required for both radiation effectiveness and radiation risk
assessment (247).
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A. Target theory
The prediction of therapeutic efficacy and of side effects of
radiation exposure relies on the establishment of dose/effect
relationships between radiation dose and tissue reactions.
Most radiobiological studies have used EBRT, generally with
gamma and X-rays (244). The biological effects induced
by radiation at medium (0.5–5 Gy) to high doses (5–15 Gy)
are quite well known (140). They are usually subdivided as
follows: (i) nonstochastic effects (also called deterministic or
tissue reaction effects) that occur above a certain threshold
(>0.5 Gy) and the severity of which increases with the dose;
and (ii) stochastic effects (genetic risks in offspring and
cancer) for which there is no threshold, but only a probability
of occurrence. The tumor tissue response to radiation (as-
similated to the tumor control probability, TCP) belongs to
the nonstochastic effects category. In EBRT, it is propor-
tional to the dose according to a sigmoid curve. At the mo-
lecular level, this curve reflects the eradication of the most
radioresistant clonogenic malignant cells present in the tu-
mor. TCP can be described using mathematical models, and
cell killing can be analyzed using the Poisson law as statis-
tical model. The ‘‘N’’ in the Poisson law defines the proba-
bility for targets to be hit N times (160, 351). Therefore, the
survival fraction (S) is the survival probability [p(0)] for a
cell that receives no lethal hit [S = p(0) = exp(-Ñ), Ñ being the
average number of lethal lesions] (324).
This model has been later replaced by a linear quadratic
(LQ) model [S = exp(-aD - bD2) where a and b are constant
parameters and D is the dose. Ñ contains linear (aD) and
quadratic (bD2) terms, indicating that lethal lesions could be
caused by one single track (aD term) or two tracks (bD2
term). In this model, two tracks (bD2 term) produce less se-
vere lesions (called sublethal lesions) that, taken individu-
ally, could be repaired in the absence of the second track
deleterious effects. Conversely, the single track of the (aD)
term corresponds to a lethal lesion. The (a/b) ratio refers to
the cell repair capacity and radiosensitivity. This formulation
has the advantage of considering both physical hits and
molecular response (148). The a/b ratio has been determined
clinically for normal tissues and tumors (17, 18, 63, 64, 138,
288). Tissues with small a/b ratio values have greater repair
capacity and are more sensitive to dose fractionation than
tissues with high ratio values.
In this context, tumor eradication means that no clonogenic
cell survives. Therefore, TCP is strictly proportional to the
number of clonogenic cells, depending on the dose: TCP =
exp(-Ns) where Ns is the number of clonogenic cells and
contains the (-aD - bD2) expression (138).
B. The clinical relevance of off-target effects might
be radiotherapy dependent
On the contrary, a general rule about the benefit/risk ratio
of off-target effects in radiotherapy might not exist because
this response is influenced by many parameters: type of ra-
diotherapy, dose ranges, dose rates, dose fractionation, and
radiation type (photons vs. charged particles). In conven-
tional EBRT, X-rays (usually 2 Gy fractions for 1–2 min) are
delivered over several days and weeks to reach the final tu-
mor biological effective dose. Improvement in conforming
irradiation to the tumor volume to protect healthy tissues has
led to the development of 3D-conformal radiation therapy
and more recently to intensity-modulated radiation therapy
(IMRT) and image-guided radiation therapy using computed
tomography, positron emission tomography, or magnetic
resonance imaging. Other irradiation modalities, including
tomotherapy, stereotactic radiosurgery, stereotactic body
radiation therapy (SBRT), involved-field radiation therapy,
have been developed (247). Therefore, it is becoming diffi-
cult to extrapolate radiobiology notions for conventional
treatment with 2 Gy$min-1 to other irradiation methods, for
instance, SBRT with high doses of radiation. High LET
particles, such as heavy carbon ions and protons, are now
routinely used in the clinic (21, 222). They take advantage of
the spread out Bragg peak (145).
Radionuclide therapy is another procedure where off-
target effects have to be considered. Radionuclides are used
for the treatment of various diseases, such as thyroid can-
cer with 131I, lymphoma with radiolabeled anti-CD20
monoclonal antibodies (90Y-ibributomab tiuxetan; Zevalin),
neuroendocrine tumors with 177Lu-DOTA0-Tyr3-octreotate
(Lutathera), neuroblastoma, carcinoid tumor, pheochromo-
cytoma, paraganglioma with 131I-meta-iodobenzylguanidine
(MIBG), bone metastases from prostate cancer with 223RaCl2,
and hepatocellular carcinoma with 90Y microspheres. Other
radionuclides are used for palliative treatment of bone me-
tastases (89Sr, 153mSr, 186Re, 188Re, 223Ra) (33), and many
other radiolabeled antibodies or peptides are currently assessed
in clinical trials.
The particularity of radionuclide therapy is that radionu-
clides are targeted by conjugation with peptides or antibodies
and are then injected in the circulation. The dose is delivered
over several hours and days, at a relatively low-dose rate. The
delivered dose can be strongly heterogeneous because of
tumor-site accessibility issues and also because of the parti-
cles used (beta, alpha, and Auger electrons). Heterogeneity
also occurs at the whole-body scale because the whole body
may be irradiated (at variable doses), although the highest
dose is delivered to the tumor. Moreover, the interplay be-
tween the radiation effects and the biological effects of
the vector should also be considered (243). Because of its
physical features, radionuclide therapy could be, to some
extent, assimilated to low-dose rate brachytherapy using
sealed sources of 125I for prostate cancer treatment. More-
over, as some of the radionuclides (e.g., 223Ra, 213Bi, 225Ac,
211At, 212Pb/212Bi) are high-LET particle emitters, some
forms of targeted radionuclide therapy show similarities, to
some extent, with external radiotherapy using other types of
high-LET particles, such as heavy ions or protons. There-
fore, there is not one form of radiotherapy but many. Con-
sequently, the assessment of the contribution of off-target
effects should be considered a major field of research
without a universal rule. For instance, Mairs’s team showed
that the bystander response to the same MIBG molecule
labeled with alpha, Auger, or beta emitters produces dif-
ferent effects (31).
C. Bystander effects and radiation protection
There is evidence of in vivo (16, 33, 228, 243, 339) and ex
vivo (16) bystander effects during EBRT and radionuclide
therapy. In conventional EBRT, bystander effects are mainly
expected to contribute significantly to the cell outcome at low
doses (<0.5 Gy) (248, 274). This is due to the observation that
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targeted effects increase with the dose, while bystander ef-
fects saturate as the dose increases. Therefore, targeted ef-
fects predominate at high dose compared with bystander
effects. Conversely, Mothersill and Seymour showed that
in vitro, cell death caused by gamma-ray doses comprised
between 0.01 and 0.5 Gy is only due to bystander effects
(274). However, bystander effects are also observed after
high-dose irradiation (26).
At doses below 0.1–0.2 Gy, only stochastic effects, in-
cluding cancer, are relevant for assessing the tissue response.
Such doses can be encountered during environmental expo-
sures and also during treatment in nontumor tissues located
at the margin of the irradiation field, or in the presence of
dose gradients, particularly in IMRT, tomotherapy, and
heavy ion particle therapy. It also concerns diagnostic ra-
diological procedures and possibly also nuclear medicine. It
must be also noted that the assessment of the dose delivered
to the tumor and healthy tissues is more difficult and chal-
lenging during radionuclide therapy than EBRT, making risk
assessment even more complicated.
The effects of such low doses, essentially cancer induction,
could be predicted by extrapolating from assessments at high
dose and by correcting for factors that account for low-dose
rate and low dose, according to a linear no-threshold (LNT)
model. The LNT model assumes that detrimental effects
decrease according to the dose rate and are proportional to
the dose. According to the ‘‘target theory’’ that relies mainly
on a DNA-centered view of radiobiology (3), detrimental
effects of radiation (mutagenesis, carcinogenesis, and cell
death) are only observed in irradiated cells (more precisely in
their nucleus) and in their progeny. This view is now chal-
lenged by the identification of harmful effects of radiation
also in nonirradiated cells (off-target effects) and their am-
plification. However, the subject is still a matter of debate
because there are many experimental and epidemiological
evidences showing that it makes sense to extrapolate the risk
from high to low doses. Nevertheless, many other studies
highlight some of the weaknesses of the target theory (140).
The theory behind off-target and bystander effects con-
siders that cells can die without being crossed by particles,
that is, without having absorbed any energy from radiation.
The ultimate consequence is that irradiated cells cannot be
considered anymore as an independent entity, the final fate
of which depends solely on the delivered dose and on their
intrinsic radiosensitivity, which is one of the bases of the
‘‘target theory.’’ Conversely, the interplays with the micro-
environment and even with the whole body through systemic
communication that involves the blood and lymphoid com-
partments have to be considered.
D. The biology of low dose and low-dose rate might
differ from that of high dose and high-dose rate
Besides bystander effects, several other phenomena, such
as inverse dose rate effect and low-dose hypersensitivity,
challenge the LNT model and risk assessment. For example,
genomic instability frequency is higher at low than at high
doses (309), and bystander effects have also been observed at
low EBRT doses and after one single alpha particle track. As
mentioned above, the RIAR shows that a priming dose
(generally >0.005 Gy) reduces the detrimental effects of the
challenging dose administered a few hours later (140, 275).
Therefore, it is likely that extrapolating data from high to
low dose cannot be corrected solely by considering that cells
have more time to repair DNA DSBs at low-dose rate, but by
considering to some extent different biological mechanisms.
E. Off-target effects and radiotherapy efficacy
The existence of off-target effects might be an advantage for
tumor eradication, although they are still difficult to control.
One of the challenges is now to define the best radiotherapy
plan (dose, dose rate, LET) and combination for promoting
these effects. There have been several approaches (247) based
on gene therapy to introduce NOS2 (328) and to use radiation-
iNOS promoters (334). Gene therapy with human telomerase
promoters associated with targeted radiotherapy using 131I-
MIBG radionuclides has also been investigated by Boyd et al.
(31). Some strategies focused on DNA because DNA repair in
bystander cells is different compared with irradiated cells and
involves ATR upstream of ATM (38, 96), highlighting the role
of stalled DNA replication forks. In this respect, BRCA1,
FANCD2, and CHK1 have been identified as potential mo-
lecular targets in bystander cells (37).
The parameters affected by new clinical practices are dose
and fractionation (hypo- and hyperfractionation). In some
way, radionuclide therapy could be assimilated to hyper-
fractionated therapy. It is clear that dose and dose fraction-
ation can modify the contribution of off-target effects to the
final outcome. It was shown that the bystander response re-
sulting from fractionated irradiation is different in tumor and
healthy tissues (203).
The dose influence on the bystander response was re-
viewed by Tomita and Maeda (307). Bystander cell death
induced by doses as low as 0.01 Gy of low LET radiation (c-
rays from 60Co) is similar to the cell death caused by expo-
sure of nonirradiated cells to conditioned medium from cells
irradiated at the same dose. It seems that there is a threshold
above 2–3 mGy and bystander response reaches a plateau
at 0.3 Gy (169). The influence of dose and dose rate on ab-
scopal effects was reviewed by Rodel et al. (258). Radiation-
induced immunosuppressive effects are observed at relatively
low and clinically relevant doses (<0.5–1 Gy) and include
depletion of immune cells, polarization of M2 macrophages,
and increase in the number of radioresistant Treg cells. Ir-
radiation immunosuppressive effects have been used as early
as 1898 to treat chronic inflammatory diseases (X-ray-treated
polyarthritis). Currently, radionuclides (89SrCl2,
153Sm-
EDTMP, or 186/188Re–HEDP) are proposed for the palliative
treatment of bone metastases. Indeed, the palliative effects of
low doses should be mediated by innate immune cells, such as
macrophages. In function of their microenvironment, macro-
phages can behave as proinflammatory actors (classically, the
activated M1 phenotype) that secrete proinflammatory cyto-
kines (IL-6, TNFa, IL-1), and chemotactic factors (IL-8 and
CCL20), or as anti-inflammatory cells (M2 macrophages).
Moreover, both initiation and resolution of inflammation
participate in tissue homeostasis. In this way, macrophages are
involved in several functions, including phagocytosis (CD31),
antigen presentation through CD40 receptors, secretion of
cytokines (TNFa or IL-1 under the control of NF-jB), ROS
release, and RNS production through iNOS.
At doses of 0.5 and 0.7 Gy, secretion of proinflammatory
cytokines (e.g., TNFa) is reduced in macrophages derived
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from human THP-1 cells and in mouse macrophages stimu-
lated by LPS (313). The TNF family is involved in ROS
production required for pathogen killing by phagocytes.
In turn, ROS activate NF-jB, leading to additional TNFa
production. However, although iNOS expression in macro-
phages is increased in inflammation, radiation seems to de-
crease its expression in some cases (268). This could be
mediated by an increase in the stress protein heme oxygenase
1 (HO-1) (123). Therefore, the anti-inflammatory effect of
low doses of ionizing radiation could be mediated by re-
duction in NO production. Moreover, low-dose irradiation
can promote secretion of the anti-inflammatory cytokines
TGFb1-3 by M2 macrophages (258, 312). Production of IL-
1b also is decreased in macrophages of radiosensitive Balb/c
mice exposed to 0.5 or 0.7 Gy of ionizing irradiation (X-ray)
(88). The authors mentioned that 0.5 Gy gamma radiation
causes upregulation of MAPK phosphatase-1 (MKP-1),
leading to inactivation of the p38 MAPK and suppression of
TNFa production.
Conversely and as previously discussed, abscopal effects
have been described in preclinical models and in patients at
higher doses than those causing bystander effects (2–40 Gy)
(258).Their occurrence and contribution to the final antitu-
mor efficacy depend on the tumor and its microenvironment.
Moreover, they are more pronounced when using therapeutic
combinations that activate the immune system, such as in-
jection of dendritic cells (87, 261). Currently, the critical
factors orchestrating the overall response of the tumor and of
the organism to irradiation are not clearly defined. Never-
theless, it is accepted that there is a synergy between tumor
response, radiation toxicity, and immune system.
F. Benefit/risk analysis: conclusion
The off-target effects of radiation are a major concern both
for radiotherapy and radiation protection. The relative con-
tribution of off-target effects to the final therapeutic efficacy
and to the detrimental effects of radiation might depend
strongly on the type of exposure (e.g., dose, low vs. high LET,
protracted vs. acute irradiation, homogeneous vs. heteroge-
neous irradiation). Off-target effects are relatively difficult to
predict and to control, but they can be advantageous for tu-
mor treatment. In EBRT, bystander effects should be pre-
dominant at low dose (0.5 Gy), compared with targeted
effects, the contribution of which increases with dose and
becomes predominant at high doses. However, the contri-
bution of off-target effects might vary in function of the ra-
diotherapy type (e.g., radionuclide therapy), although the
response is expected to reach a plateau. On the contrary,
abscopal effects could be exploited at higher doses, by using
appropriate treatment combinations and doses.
Radiation protection systems rely on the LNT model. Al-
though it is now clear that off-target effects (e.g., bystander
and abscopal effects) must be considered both at low and high
doses, it is still not known whether epidemiologically, these
effects will be traduced statistically to an increase or decrease
of the risk for healthy tissues. Although new findings high-
light the possible role of off-target and delayed cellular ef-
fects, UNSCEAR considers that the current risk estimates for
irradiation-induced cancer and hereditary effects in humans
do not need to be changed.
VI. General Conclusion
In this review, we presented in an analytical way the cur-
rent status of knowledge in the area of off-target and away-
from-target ionizing radiation effects with special emphasis
on their role on radiation therapy and clinical applications.
After years of intensive in vitro and in vivo (animals) research
and circumstantial clinical evidence in humans, the idea of off-
target effects has gained high interest and is increasingly ac-
cepted by the scientific community. It is certainly considered a
paradigm shift from the target theory in radiation biology
where biological important components of the cells must be
directly hit from radiation to show a radiation response.
Undoubtedly, radiation harmful effects are linked to the
induction of a high percentage of clustered lesions that de-
stroy the target (i.e., any cellular component, but particularly
DNA, proteins, and the cell membrane with its lipids). Al-
though in this review, we focused on DNA, we cannot dis-
regard the importance of other cell targets that could contribute
to the radiation response and systemic effects in the organism.
We also believe that ionizing radiation effects must be eval-
uated at the whole organism level and not just in the directly hit
area. Therefore, we discussed the prevailing mechanisms un-
derlying off-target effects, particularly the release of radical
species (ROS/RNS) from the irradiated area, induction of the
DDR, and repair and activation of a variety of danger/stress
signals that relate to the various forms of radiation injury and
apoptosis (Figs. 6 and 14). The result is usually a proin-
flammatory response and in many cases, the activation of the
immune system, a process that shows many similarities with
the stress response on damage or pathogen intrusion. We de-
scribed all the key molecules that participate in this process,
such as the NF-jB/COX-2 signaling pathways, and the rele-
vant experimental evidence. We also discussed the emerging
view on the role of complex DNA damage because from an
evolutionary point of view, this is the only discriminating
factor between irradiation-induced and endogenous oxidative
stress-induced damage (Fig. 15).
We then discussed the clinical importance of these mo-
lecular mechanisms and of the association between targeted
and off-target radiation mechanisms. We described the ex-
isting evidence for the systemic nature of radiation effects
(i.e., abscopal phenomenon). In our opinion, abscopal effects
are a genuine manifestation of the holistic nature of the body
response to radiation, even when administered to a localized
area. Strong in vivo evidence in various model organisms
(from animals to humans) supports the induction of radiation
effects at sites distant from the irradiation site. Many of these
studies reported tumor regression and the involvement of the
innate immune system, thus underlying the strong links be-
tween the radiation response mechanisms (e.g., DNA damage
sensing, DNA repair, and apoptosis) and immune system ac-
tivation. The involvement of the immune system is supported
by the finding that the combination of radiation with immune
system-boosting drugs, such as the anti-PD-1 (MEDI0680) or
anti-CTLA-4 (AGEN1884) monoclonal antibodies, led to a
reduction of the size of a metastatic nonirradiated tumor and of
cancer spread in the body. These new treatments that combine
radiation and immunotherapies are based on radiation biology
data showing that the radiation response occurs at the whole-
organism level, something which was often disregarded up to
few years ago. Although many questions on the propagation
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mechanisms of off-target effects still exist, these new concepts
open the way for the development of more efficient radiation-
based immunotherapies and other adjuvant therapies.
VII. Key Points
Cell damage is mediated by the direct interaction of ion-
izing radiation with water and cellular constituents, such as
DNA, lipids, and proteins.
Radiation generates ‘‘danger’’ signals that propagate from
irradiated to nonirradiated cells, leading to off-target (by-
stander and abscopal/distant) effects.
Redox mechanisms also play a key role in both targeted
and off-target radiation effects.
NF-jB is essential for triggering the self-sustained pro-
duction of reactive oxygen and nitrogen species (ROS and
RNS) that are involved in both targeted and off-target radi-
ation effects.
The level of damage produced by radiation is relatively
lower than that caused by endogenous oxidative stress.
The harmful effects of radiation are explained not only by
the induction of closely spaced (clustered) DNA lesions but
also by the amplification of the initial radiation-induced
cellular response.
Immune cells can be recruited and contribute to the distant
(abscopal) effects of irradiation with potential clinical im-
plications.
Differently from targeted effects (e.g., the induction of
DNA damage), off-target effects are not strictly dose related.
Although there is evidence of off-target effects existence
in vivo through the mediation of the immune system and of
their applicability in cancer immunotherapy (e.g., use of
immune checkpoint inhibitors), they are still difficult to
predict and control.
Off-target effects contribution is likely to depend on the
irradiation physical parameters (type and level of damage) as
well as on the type of tissue and organism.
Radiation-induced systemic phenomena (as opposed to
localized, direct damage) represent a radiobiology paradigm
shift and must be taken into account in radiation protection as
well as in radiotherapy.
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Abbreviations Used
3D¼ three dimensional
4-HNE¼ 4-hydroxy-2-nonenal
53BP1¼ p53-binding protein 1
8-oxodGuo¼ 8-oxo-7¢8-dihydro-2¢-deoxyguanosine
ASMase¼ acid sphingomyelinase
ATM¼ ataxia-telangiectasia mutated
ATR¼ATM- and RAD3-related
BRCA1¼ breast cancer type 1
CHK1¼ checkpoint kinase 1
CHK2¼ checkpoint kinase 2
cNOS¼ constitutive nitric oxide synthase
COX-2¼ cyclooxygenase 2
c-PTIO¼ 2-4-carboxyphenyl-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide
CtIP¼C-terminal-binding protein 1-interacting
protein
CTL¼ cytotoxic T lymphocyte
CuZnSOD¼Cu–Zn-dependent superoxide dismutase
Cxs¼ connexins
DAMPS¼ damage-associated-molecular-patterns
DDR¼DNA damage response
DNA-PK¼DNA-dependent protein kinase
DSBs¼ double-strand breaks
dsDNA¼ double-stranded DNA
DUOX¼ dual oxidase
EBRT¼ external beam radiotherapy
EGFR¼ epidermal growth factor receptor
eNOS¼ endothelial nitric oxide synthase
ER¼ endoplasmic reticulum
ERK¼ extracellular signal-regulated kinases
ETC¼ electron transport chain
FAD¼ flavin adenine dinucleotide
FANCD2¼ Fanconi anemia group D2 protein
FAK¼ focal adhesion kinase
FAT¼ FRAP-ATM- TRRAP
FATC¼ FAT C terminal
Flt3-L¼ Flt3-Ligand
GJIC¼ gap junction intercellular communication
GPCRs¼G-protein-coupled receptors
GPx¼ glutathione peroxidase
GSH¼ glutathione
H2O2¼ hydrogen peroxide
HOCl¼ hypochlorous acid
HRR¼ homologous recombination repair
IAP¼ inhibitor-of-apoptosis
IGF-1¼ insulin-like growth factor 1
IKK¼ IjB kinase
IMRT¼ intensity-modulated radiation therapy
iNOS¼ inducible NO synthase
IP3¼ inositol trisphosphate
JNKs¼ c-Jun N-terminal kinases
JAK2¼ Janus kinase 2
LET¼ linear energy transfer
L-NAME¼NG-nitro-L-arginine methyl ester
LNT¼ linear no-threshold
LPS¼ lipopolysaccharide
MAPK¼mitogen-activated protein kinase
MDC1¼mediator of DNA damage checkpoint
protein 1
MDA¼malondialdehyde
MDM2¼mouse double minute 2 homologue
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Abbreviations Used (Cont.)
MDS¼multiple damage sites
MIBG¼meta-iodobenzylguanidine
MMP¼matrix metalloproteinase
MN¼micronuclei
MnSOD¼manganese-dependent superoxide
dismutase
MRN¼MRE11–RAD50–NBS1
mtDNA¼mitochondrial DNA
NAD(P)H¼ nicotine adenine dinucleotide phosphate
NEMO¼NF-jB essential modulator
NF-jB¼ nuclear factor kappa B
NHEJ¼ nonhomologous end joining
NO¼ nitric oxide
NOS¼ nitric oxide synthase
NOX¼NAD(P)H oxidase
O2
-¼ superoxide anion
ONOO-¼ peroxynitrite
Panxs¼ pannexins
PGE2¼ prostaglandin E2
PI3K¼ phosphatidylinositol-3-kinase
PIG¼ p53-induced genes
PKC¼ protein kinase C
PLC¼ phospholipase C
PP2A¼ protein phosphatase 2
PRRs¼ pattern recognition receptors
PUFA¼ polyunsaturated fatty acids
PUMA¼ p53-upregulated modulator of apoptosis
RIAR¼ radiation-induced adaptive response
RNS¼ reactive nitrogen species
ROS¼ reactive oxygen species
SBRT¼ stereotactic body radiation therapy
SOD¼ superoxide dismutase
SSBs¼ single-strand breaks
STAT3¼ signal transducer and activator of
transcription 3
TCP¼ tumor control probability
TGF¼ transforming growth factor
TLR¼Toll-like receptor
TNF¼ tumor necrosis factor
TRADD¼TNFR type 1-associated DEATH
domain protein
TRAF2¼TNF receptor-associated factor 2
TRAIL¼TNF-related apoptosis-inducing ligand
Treg cells¼ regulatory T cells
UNSCEAR¼United Nations Scientific Committee
on the Effects of Atomic Radiation
VDACs¼ voltage-dependent anion channels
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